WO2013000941A1 - Microbiocidal heterocycles - Google Patents

Microbiocidal heterocycles Download PDF

Info

Publication number
WO2013000941A1
WO2013000941A1 PCT/EP2012/062425 EP2012062425W WO2013000941A1 WO 2013000941 A1 WO2013000941 A1 WO 2013000941A1 EP 2012062425 W EP2012062425 W EP 2012062425W WO 2013000941 A1 WO2013000941 A1 WO 2013000941A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
alkyl
bond
hydrogen
halogen
Prior art date
Application number
PCT/EP2012/062425
Other languages
French (fr)
Inventor
Sarah Sulzer-Mosse
Clemens Lamberth
Fredrik Emil Malcolm Cederbaum
Original Assignee
Syngenta Participations Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Participations Ag filed Critical Syngenta Participations Ag
Publication of WO2013000941A1 publication Critical patent/WO2013000941A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/761,3-Oxazoles; Hydrogenated 1,3-oxazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/781,3-Thiazoles; Hydrogenated 1,3-thiazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/82Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Definitions

  • the present invention relates to heterocycles, e.g. as active ingredients, which have microbiocidal activity, in particular fungicidal activity.
  • the invention also relates to preparation of these heterocycles, to heterocyclic derivatives used as intermediates in the preparation of these heterocycles, to preparation of these intermediates, to agrochemical compositions which comprise at least one of the heterocycles, to preparation of these compositions and to use of the heterocycles or compositions in agriculture or horticulture for controlling or preventing infestation of plants, harvested food crops, seeds or non-living materials by phytopathogenic microorganisms, preferably fungi.
  • the present invention provides compounds of formula I:
  • T is CR 18 or N
  • G is O or S
  • Y 1 and Y 2 are independently CR 19 or N;
  • n 1 or 2;
  • p is 1 or 2, providing that when n is 2, p is 1 ;
  • R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 10 - R 11 - R 12 ' R 13 ' R 16 ' R 17 ' R 18 ' R 19 and R26 eac h independently are hydrogen, halogen, cyano, C 1 -C 4 al k yl or C 1 -C 4 haioaikyl;
  • R 8 , R 14 , R 15 , R 20 and R 21 each independently are hydrogen, C-
  • phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C C alkyl, C C haloalkyi, C C alkoxy, C C haloalkoxy, halogen, cyano, hydroxyl, N(R 27 ) 2 , SH, Ci-C alkylthio, nitro, phenylsulfonyl and phenylsulfinyl, wherein the phenylsulfonyl and phenylsulfinyl are optionally substituted by 1 to 3 substituents independently selected from Ci-C alkyl, C C haloalkyi, Ci-C alkoxy, Ci- C haloalkoxy, halogen and cyano;
  • each R 27 independently is hydrogen, d-C alkyl, phenylsulfonyl or phenylsulfinyl, wherein the phenylsulfonyl and phenylsulfinyl are optionally substituted by 1 to 3 substituents independently selected from C C alkyl, C C haloalkyi, C C alkoxy, C C haloalkoxy, halogen and cyano; or a salt or a N-oxide thereof.
  • substituents are indicated as being optionally substituted, this means that they may or may not carry one or more identical or different substituents. Normally not more than three such optional substituents are present at the same time.
  • halogen refers to fluorine, chlorine, bromine or iodine, preferably fluorine, chlorine or bromine.
  • amino refers to -NH 2 .
  • Alkyl substituents may be straight-chained or branched. Alkyl on its own or as part of another substituent is, depending upon the number of carbon atoms mentioned, for example, methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl and the isomers thereof, for example, iso-propyl, iso-butyl, sec-butyl, tert-butyl, iso-amyl or pivaloyl.
  • a haloalkyi group may contain one or more identical or different halogen atoms and, for example, may stand for CH 2 CI, CHCI 2 , CCI 3 , CH 2 F, CHF 2 , CF 3 , CF 3 CH 2 , CH 3 CF 2 , CF 3 CF 2 or CCI 3 CCI 2 .
  • the presence of one or more possible asymmetric carbon atoms in a compound of formula I means that the compounds may occur in optically isomeric forms, i.e.
  • Formula I is intended to include all those possible isomeric forms and mixtures thereof.
  • the present invention includes all those possible isomeric forms and mixtures thereof for a compound of formula I.
  • formula I is intended to include all possible tautomers.
  • the present invention includes all possible tautomeric forms for a compound of formula I.
  • the compounds of formula I according to the invention are in free form, in oxidized form as a N-oxide or in salt form, e.g. an agronomically usable salt form.
  • N-oxides are oxidized forms of tertiary amines or oxidized forms of nitrogen containing heteroaromatic compounds. They are described for instance in the book "Heterocyclic N- oxides" by A. Albini and S. Pietra, CRC Press, Boca Raton 1991.
  • Suitable salts of the compounds of formula I include those resulting after addition of acid such as those with an inorganic mineral acid e.g. hydrochloric, hydrobromic, sulphuric, nitric or phosphoric acid, or an organic carboxylic acid e.g. oxalic, tartaric, lactic, butyric, toluic, hexanoic or phthalic acid, or a sulfonic acid e.g. methane, benzene or toluene sulfonic acid.
  • an inorganic mineral acid e.g. hydrochloric, hydrobromic, sulphuric, nitric or phosphoric acid
  • organic carboxylic acid e.g. oxalic, tartaric, lactic, butyric, toluic, hexanoic or phthalic acid
  • a sulfonic acid e.g. methane, benzene or toluene sulfonic acid
  • the compound of formula I is a compound wherein:
  • T is CR 18 or N
  • G is O or S
  • Y 1 and Y 2 are independently CR 19 or N;
  • n 1 or 2;
  • p is 1 or 2, providing that when n is 2, p is 1 ;
  • R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 10 , R 11 , R 12 , R 13 , R 16 , R 17 , R 18 and R 19 each independently are hydrogen, halogen, cyano, CrC 4 alkyl, or Ci-C 4 haloalkyl;
  • R 8 , R 14 , R 15 , R 20 and R 21 each independently are hydrogen or C C 4 alkyl
  • R 9 is phenyl, benzyl or group (a):
  • phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C-
  • the compound of formula I is a compound wherein:
  • T is CR 18 or N
  • G is O or S
  • Y 1 is N
  • Y 2 is CR 19 or N
  • n 1 or 2;
  • p 1 ;
  • R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 10 , R 11 , R 12 , R 13 , R 16 , R 17 , R 18 and R 19 each independently are hydrogen, halogen, d-C 4 alkyl, Ci-C 4 haloalkyl;
  • R 8 , R 20 and R 21 each independently are hydrogen or CrC 4 alkyl
  • R 9 is henyl, benzyl or group (a):
  • phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C-
  • the compound of formula I is a compound wherein:
  • T is CR 18 or N
  • G is S
  • Y 1 is N
  • Y 2 is CR 19 or N;
  • n is 1 or 2;
  • p 1 ;
  • R 8 and R 20 each independently are hydrogen or methyl
  • R 9 is henyl, benzyl or group (a):
  • phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C1-C4 alkyl, C C 4 haloalkyi, hydroxy and halogen.
  • the compound of formula I is a compound wherein:
  • T CH or N
  • G is S
  • Y 1 is N
  • Y 2 is CH or N
  • n 1 or 2;
  • p 1 ;
  • R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are each hydrogen;
  • R 8 is hydrogen
  • R 9 is henyl, benzyl or group (a):
  • phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C C 4 alkyl, C C 4 haloalkyi, hydroxy and halogen.
  • the compound of formula I is a compound wherein:
  • T CH
  • G is S
  • n 2;
  • p 1 ;
  • R 2 , R3, R 4 , R5, R6, and R 7 are each hydrogen;
  • R 8 is hydrogen
  • R 9 is henyl, benzyl or group (a):
  • phenyl, benzyl and group (a) are optionally substituted with 1 to 3 substituents independently selected from halogen, hydroxy, methyl and halomethyl.
  • the invention also provides a compound of formula I in which:
  • T CH or N
  • G is O or S
  • Y 1 is N
  • Y 2 is CH or N
  • n 1 or 2;
  • p is 1 or 2, providing that when n is 2, p is 1 ;
  • R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are H;
  • R 8 is H or methyl
  • R 9 is roup (i), Q), (k), (I) or (m):
  • x indicates the bond that is connected to R 1 .
  • T is CR 18 or N.
  • T is CH or N. More preferably, T is CH.
  • G is O or S.
  • G is S.
  • Y 1 is CR 19 or N.
  • Y 1 is N.
  • Y 2 is CR 19 or N.
  • Y 2 is CH or N. More preferably, Y 2 is CH.
  • n 1 or 2.
  • n is 2.
  • p is 1 or 2, providing that when n is 2, p is 1 .
  • p is 1.
  • R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 10 , R 11 , R 12 , R 13 , R 16 , R 17 , R 18 , R 19 each independently are hydrogen, halogen, cyano, C C 4 alkyl, or Ci-C 4 haloalkyl.
  • R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 10 , R 11 , R 12 , R 13 , R 16 , R 17 , R 18 and R 19 each independently are hydrogen, halogen, C C 4 alkyl, or C C 4 haloalkyl.
  • R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 10 , R 11 , R 12 , R 13 , R 16 , R 17 , R 18 and R 19 each independently are hydrogen, fluoro, or methyl. Even more preferably, R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 10 , R 11 , R 12 , R 13 , R 16 , R 17 , R 18 and R 19 each independently are hydrogen.
  • R 8 , R 14 , R 15 , R 20 , and R 21 each independently are hydrogen or d-C 4 alkyl.
  • R 8 , R 14 , R 15 , R 20 , and R 21 each independently are hydrogen or methyl.
  • R 8 , R 14 , R 15 , R 20 , and R 21 each independently are hydrogen.
  • R 9 is henyl, benzyl or group (a):
  • phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C1-C4 alkyl, C1-C4 haloalkyi, C1-C4 alkoxy, Ci-C 4 haloalkoxy, halogen, cyano, hydroxyl, N(R 27 ) 2 , SH, C-
  • R 9 is phenyl, benzyl or group (a):
  • phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C1-C4 alkyl, C1-C4 haloalkyi, halogen, cyano, h droxy and amino.
  • R 9 is phenyl, benzyl or group (a):
  • phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C-
  • R 26 is hydrogen, halogen, cyano, CrC 4 alkyl, or Ci-C 4 haloalkyl.
  • R 26 is hydrogen, halogen, Ci-C 4 alkyl, or Ci-C 4 haloalkyl.
  • R 26 is hydrogen, fluoro, or methyl. More preferably, R 26 is hydrogen.
  • Each R 27 independently is hydrogen, d-C 4 alkyl, phenylsulfonyl or phenylsulfinyl, wherein the phenylsulfonyl and phenylsulfinyl are optionally substituted by 1 to 3
  • R 27 is independently is hydrogen, Ci-C 4 alkyl, phenylsulfonyl or phenylsulfinyl, wherein the phenylsulfonyl and phenylsulfinyl are optionally substituted by 1 to 3 substituents independently selected from halogen, methyl and halomethyl.
  • R 9 In one roup of compounds R 9 is group (i), (j), (k), (I) or (m):
  • G is S, Y 1 is N and Y 2 is CH.
  • R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are H.
  • R 9 is phenyl substituted by hydroxyl, and optionally substituted by one or two further substituents as defined above.
  • the hydroxy is at the ortho position.
  • one of the further substituents is halogen and is preferably at the meta position adjacent to the hydroxy.
  • A, T, G, Y 1 , Y 2 , Q, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 have the definitions as described for formula I.
  • A, T, G, Y 1 , Y 2 , Q, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 have the definitions as described for formula I.
  • the invention also relates to compounds of formula IA, formula IB and formula IC as shown above.
  • A, G, Y 1 , Y 2 , Q, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 have the definitions as described for formula I.
  • Preferred definitions of A, G, Y 1 , Y 2 , Q, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are as defined for formula I.
  • the invention also relates to compounds of formula IE:
  • A, Q, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 have the definitions as described for formula I.
  • Preferred definitions of A, Q, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are as defined for formula I.
  • the invention also relates to compounds of formula IF:
  • T is CH or N
  • R 8 is CH 3 or H
  • R 1 and R 9 have the definitions as described for formula I. Preferred definitions of R 1 and R 9 are as defined for formula I.
  • the invention also relates to compounds of formula IG:
  • T is CH or N
  • R 8 is CH 3 or H
  • R 9 has the definition as described for formula I. Preferred definitions of R 9 are as defined for formula I.
  • the invention also includes compounds of formula II:
  • R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , A, T, G, Y 1 , Y 2 , p and n are as defined for formula I.
  • Preferred definitions of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , A, T, G, Y 1 , Y 2 , p and n are as defined for formula I.
  • Compounds of formula II are useful as intermediates in the synthesis of compounds of formula I.
  • the invention also includes compounds of formula VIII:
  • R 1 , R 2 , R 3 , R 4 , R 6 , R 7 , R 8 , A, T, G, Y 1 , Y 2 , p and n are as defined for formula I.
  • Preferred definitions of R 1 , R 2 , R 3 , R 4 , R 6 , R 7 , R 8 , A, T, G, Y 1 , Y 2 , p and n are as defined for formula I.
  • Compounds of formula VII I are useful as intermediates in the synthesis of compounds of formula I .
  • the compounds of formula I wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , A, T, G, Y 1 , Y 2 , n, p and Q are as defined for formula I can be obtained by transformation of a compound of formula I I , wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , A, T, G, Y 1 , Y 2 , n, p and Y are as defined for formula I with a compound of formula I I I, wherein R 9 and Q are as defined for formula I and X is a hydroxy, halogen, preferably fluoro, chloro or bromo or alkoxy, such as methoxy, ethoxy. This is shown in Scheme 1 .
  • the compounds of formula 11.1 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A, T, G, n, p, Y 1 and Y 2 are as defined for formula I , can be obtained by transformation of a compound of formula IV, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A, T, G, n, p, Y 1 and Y 2 are as defined for formula I with an azide, such as diphenyl phosphoryl azide and subsequent Curtius rearrangement of the resulting acyl azide with an alcohol R 28 -OH, wherein R 28 is Ci-C 6 alkyl or optionally substituted aryl and following carbamate cleavage with a mineral acid, such as hydrochloric acid, sulfuric acid or an organic acid, such as trifluoroacetic acid. This is shown in Scheme 2.
  • the compounds of formula IV wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A, T, G, n, p, Y 1 and Y 2 are as defined for formula I can be obtained by saponification of a compound of formula V, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A, T, G, n, p, Y 1 and Y 2 are as defined for formula I and R 28 is CrC 6 alkyl or optionally substituted aryl with a base, such as sodium hydroxide, potassium hydroxide or lithium hydroxide. This is shown in Scheme 3.
  • the compounds of formula 1.1 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 , A, T, G, n, Y 1 and Y 2 are as defined for formula I and R 29 is Ci-C 6 alkyl can be obtained by transformation of a compound of formula 1.2, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 , A, T, G, n, Y 1 and Y 2 are as defined for formula I with an alkyl halide R 29 -Hal, wherein R 29 is C C 6 alkyl and Hal is halogen, preferably chloro or bromo. This is shown in Scheme 5.
  • the compounds of formula I.2, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 , A, T, G, n, p, Y 1 and Y 2 are as defined for formula I can be obtained by transformation of a compound of formula IV, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A, T, G, n, p, Y 1 and Y 2 are as defined for formula I with an azide, such as diphenyl phosphoryl azide and subsequent Curtius rearrangement of the resulting acyl azide with a Grignard reagent R 9 -Mg-Hal, wherein R 9 is as defined for formula I and Hal is halogen, preferably chloro, bromo or iodo, or a boronic acid R 9 -B(OH) 2 , wherein R 9 is as defined for formula I and a catalyst, such as
  • the compounds of formula 1.3 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 , A, T, G, n, p, Y 1 and Y 2 are as defined for formula I and R 29 is CrC 6 alkyl
  • R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 , A, T, G, n, p, Y 1 and Y 2 are as defined for formula I with an alkyl halide R 29 -Hal, wherein R 29 is C C 6 alkyl and Hal is halogen, preferably chloro or bromo. This is shown in Scheme 7.
  • the compounds of formula I.4, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 , A, T, G, n, p, Y 1 and Y 2 are as defined for formula I can be obtained by transformation of a compound of formula IV, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A, T, G, n, p, Y 1 and Y 2 are as defined for formula I with an azide, such as diphenyl phosphoryl azide and subsequent Curtius rearrangement of the resulting acyl azide with an alcohol R 9 -OH, wherein R 9 is as defined for formula I as defined for formula I. This is shown in Scheme 8.
  • the compounds of formula 1.5 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 , A, T, G, n, Y 1 and Y 2 are as defined for formula I and R 29 is CrC 6 alkyl
  • R 29 is CrC 6 alkyl
  • R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 , A, T, G, n, Y 1 and Y 2 are as defined for formula I with an alkyl halide R 29 -Hal, wherein R 29 is C C 6 alkyl and Hal is halogen, preferably chloro or bromo.
  • the compounds of formula 1.7 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , A, G, n, p, Y 1 , Y 2 and Q are as defined for formula I, can be obtained by reduction of a compound of formula VIII, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , A, G, n, p, Y 1 , Y 2 and Q are as defined for formula I with hydrogen and a catalyst, such as palladium on charcoal, platinum or raney-nickel. This is shown in Scheme 1 1.
  • the compounds of formula V.1 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A, G, n, p, Y 1 and Y 2 are as defined for formula I and R 28 is C-
  • the compounds of formula VIII wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , A, G, n, p, Y 1 , Y 2 and Q are as defined for formula I
  • a compound of formula XIV wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , A, G, n, p, Y 1 , and Y 2 are as defined for formula I
  • a compound of formula XV wherein R 8 , R 9 and Q are as defined for formula I and a ligand such as Xantphos or dimethylethylenediamine and a catalyst, such as Pd(OAc) 2 or copperiodide.
  • the compounds of formula XIV, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A, G, n, p, Y 1 and Y 2 are as defined for formula I can be obtained by cross coupling of a compound of formula XVI, wherein G, Y 1 and Y 2 are as defined for formula I, with a compound of formula XIII, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and A are as defined for formula I and R 30 is B(OH) 2 and a transition metal, such as bis-(triphenylphosphine)palladium(ll) chloride. This is shown in Scheme 16.
  • novel compounds of formula I have, for practical purposes, a very advantageous level of biological activity for protecting plants against diseases that are caused by fungi.
  • the compounds of formula I can be used in the agricultural sector and related fields of use e.g. as active ingredients for controlling plant pests or on non-living materials for control of spoilage microorganisms or organisms potentially harmful to man.
  • the novel compounds are distinguished by excellent activity at low rates of application, by being well tolerated by plants and by being environmentally safe. They have very useful curative, preventive and systemic properties and may be used for protecting numerous cultivated plants.
  • the compounds of formula I can be used to inhibit or destroy the pests that occur on plants or parts of plants (fruit, blossoms, leaves, stems, tubers, roots) of different crops of useful plants, while at the same time protecting also those parts of the plants that grow later e.g. from phytopathogenic microorganisms.
  • compounds of formula I as dressing agents for the treatment of plant propagation material, e.g., seed, such as fruits, tubers or grains, or plant cuttings (for example rice), for the protection against fungal infections as well as against
  • the propagation material can be treated with a composition comprising a compound of formula I before planting: seed, for example, can be dressed before being sown.
  • the active ingredients according to the invention can also be applied to grains (coating), either by impregnating the seeds in a liquid formulation or by coating them with a solid formulation.
  • the composition can also be applied to the planting site when the propagation material is being planted, for example, to the seed furrow during sowing.
  • the invention relates also to such methods of treating plant propagation material and to the plant propagation material so treated.
  • the compounds according to present invention can be used for controlling fungi in related areas, for example in the protection of technical materials, including wood and wood related technical products, in food storage, in hygiene
  • the invention could be used to protect non-living materials from fungal attack, e.g. lumber, wall boards and paint.
  • the compounds of formula I are, for example, effective against the phytopathogenic fungi of the following classes: Fungi imperfecti (e.g. Alternaria spp.), Basidiomycetes (e.g. Corticium spp., Ceratobasidium spp., Waitea spp., Thanatephorus spp., Rhizoctonia spp., Hemileia spp., Puccinia spp., Phakopsora spp., Ustilago spp., Tilletia spp.), Ascomycetes (e.g.
  • Venturia spp. Blumeria spp., Erysiphe spp., Podosphaera spp., Uncinula spp., Monilinia spp., Sclerotinia spp., Colletotrichum spp., Glomerella spp., Fusarium spp., Gibberella spp., Monographella spp., Phaeosphaeria spp., Mycosphaerella spp.,
  • Cercospora spp. Pyrenophora spp., Rhynchosporium spp., Magnaporthe spp.,
  • Oomycetes e.g. Phytophthora spp., Pythium spp., Plasmopara spp., Peronospora spp., Pseudoperonospora spp. Bremia spp.
  • Outstanding activity is observed against downy mildew (e.g. Plasmopara viticola) and late blight (e.g. Phytophthora infestans).
  • novel compounds of formula I are effective against phytopathogenic gram negative and gram positive bacteria (e.g. Xanthomonas spp, Pseudomonas spp, Erwinia amylovora, Ralstonia spp.) and viruses (e.g. tobacco mosaic virus).
  • phytopathogenic gram negative and gram positive bacteria e.g. Xanthomonas spp, Pseudomonas spp, Erwinia amylovora, Ralstonia spp.
  • viruses e.g. tobacco mosaic virus
  • target crops and/or useful plants to be protected typically comprise the following species of plants: cereal (wheat, barley, rye, oat, rice, maize, sorghum and related species); beet (sugar beet and fodder beet); pomes, drupes and soft fruit (apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries and blackberries); leguminous plants (beans, lentils, peas, soybeans); oil plants (rape, mustard, poppy, olives, sunflowers, coconut, castor oil plants, cocoa beans, groundnuts); cucumber plants (pumpkins, cucumbers, melons); fibre plants (cotton, flax, hemp, jute); citrus fruit (oranges, lemons, grapefruit, mandarins); vegetables (spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, paprika); lauraceae (avocado, cinnamomum, camphor)
  • the useful plants and / or target crops in accordance with the invention include conventional as well as genetically enhanced or engineered varieties such as, for example, insect resistant (e.g. Bt. and VIP varieties) as well as disease resistant, herbicide tolerant (e.g. glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady® and LibertyLink®) and nematode tolerant varieties.
  • suitable genetically enhanced or engineered crop varieties include the
  • useful plants and/or “target crops” is to be understood as including also useful plants that have been rendered tolerant to herbicides like bromoxynil or classes of herbicides (such as, for example, HPPD inhibitors, ALS inhibitors, for example
  • EPSPS 5-enol-pyrovyl-shikimate-3- phosphate-synthase
  • GS glutamine synthetase inhibitors
  • imidazolinones e.g. imazamox
  • Clearfield® summer rape Canola
  • crops that have been rendered tolerant to herbicides or classes of herbicides by genetic engineering methods include glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names
  • useful plants and/or “target crops” is to be understood as including also useful plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.
  • useful plants and/or target crops is to be understood as including also useful plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising antipathogenic substances having a selective action, such as, for example, the so-called “pathogenesis-related proteins” (PRPs, see e.g. EP-A-0 392 225).
  • PRPs pathogenesis-related proteins
  • Examples of such antipathogenic substances and transgenic plants capable of synthesising such antipathogenic substances are known, for example, from EP-A-0 392 225, WO 95/33818, and EP-A-0 353 191.
  • the methods of producing such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above.
  • locus of a plant as used herein is intended to embrace the place on which the plants are growing, where the plant propagation materials of the plants are sown or where the plant propagation materials of the plants will be placed into the soil.
  • An example for such a locus is a field, on which crop plants are growing.
  • plant propagation material is understood to denote generative parts of the plant, such as seeds, which can be used for the multiplication of the latter, and vegetative material, such as cuttings or tubers, for example potatoes. There may be mentioned for example seeds (in the strict sense), roots, fruits, tubers, bulbs, rhizomes and parts of plants. Germinated plants and young plants which are to be transplanted after germination or after emergence from the soil, may also be mentioned. These young plants may be protected before transplantation by a total or partial treatment by immersion. Preferably "plant propagation material” is understood to denote seeds.
  • the compounds of formula I may be used in unmodified form or, preferably, together with the adjuvants conventionally employed in the art of formulation. To this end they may be conveniently formulated in known manner to emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions or suspensions, dilute emulsions, wettable powders, soluble powders, dusts, granulates, and also encapsulations e.g. in polymeric substances. As with the type of the compositions, the methods of application, such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances. The compositions may also contain further adjuvants such as stabilizers, antifoams, viscosity regulators, binders or tackifiers as well as fertilizers, micronutrient donors or other formulations for obtaining special effects.
  • Suitable carriers and adjuvants can be solid or liquid and are substances useful in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers.
  • Such carriers are for example described in WO 97/33890.
  • the compounds of formula I are normally used in the form of compositions and can be applied to the crop area or plant to be treated, simultaneously or in succession with further compounds.
  • further compounds can be e.g. fertilizers or micronutrient donors or other preparations, which influence the growth of plants. They can also be selective herbicides or non-selective herbicides as well as insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of these preparations, if desired together with further carriers, surfactants or application promoting adjuvants customarily employed in the art of formulation.
  • the compounds of formula I may be used in the form of fungicidal compositions for controlling or protecting against phytopathogenic microorganisms, comprising as active ingredient at least one compound of formula I or of at least one preferred individual compound as above-defined, in free form or in agrochemically usable salt form, and at least one of the above-mentioned adjuvants.
  • the invention provides a fungicidal composition
  • a fungicidal composition comprising at least one compound formula I an agriculturally acceptable carrier and optionally an adjuvant.
  • An agricultural acceptable carrier is for example a carrier that is suitable for agricultural use.
  • Agricultural carriers are well known in the art.
  • said fungicidal compositions may comprise an additional fungicidal active ingredient in addition to the compound of formula I.
  • the compound of formula (I) may be the sole active ingredient of a composition or it may be admixed with one or more additional active ingredients such as an insecticide, fungicide, synergist, herbicide or plant growth regulator where appropriate.
  • An additional active ingredient may, in some cases, result in unexpected synergistic activities.
  • Suitable additional active ingredients include the following: Azoxystrobin (131860-33-8), Dimoxystrobin (149961-52-4), Enestrobin (238410-1 1 -2), Fluoxastrobin (193740-76-0), Kresoxim-methyl (143390-89-0), Metominostrobin (133408-50-1 ), Orysastrobin (248593-16- 0), Picoxystrobin (1 17428-22-5), Pyraclostrobin (175013-18-0), Azaconazole (60207-31-0), Bromuconazole (1 16255-48-2), Cyproconazole (94361 -06-5), Difenoconazole (1 19446-68- 3), Diniconazole (83657-24-3), Diniconazole-M (83657-18-5), Epoxiconazole (13385-98-8), Fenbuconazole (1 14369-43-6), Fluquinconazole (136426-54-5), Flusilazole (85509-19-9), Flutriafol (7
  • Triticonazole 131983-72-7
  • Diclobutrazol 76738-62-0
  • Etaconazole 60207-93-4
  • Fluconazole 86386-73-4
  • Fluconazole-cis 1 12839-32-4
  • Thiabendazole 148-79-8
  • Quinconazole 103970-75-8
  • Fenpiclonil 74738-17-3
  • Fludioxonil 131341-86-1
  • Tridemorph (81412-43-3), Fenpropidin (67306-00-7), Spiroxamine (1 18134-30-8),
  • Trifloxystrobin 141517-21 -7
  • Sulfur 7704-34-9
  • Copper ammoniumcarbonate CAS 331 13-08-5
  • Copper oleate CAS 1 120-44-1
  • Folpet 133-07-3
  • Quinoxyfen (124495-18- 7
  • Captan 133-06-2
  • Fenhexamid (126833-17-8
  • Glufosinate and its salts 51276-47-2, 35597-44-5 (S-isomer)
  • Glyphosate (1071-83-6 ) and its salts (69254-40-6 (Diammonium), 34494-04-7 (Dimethylammonium), 38641 -94-0 (Isopropylammonium), 40465-66-5
  • Another aspect of invention is related to the use of a compound of formula I or of a preferred individual compound as above-defined, of a composition comprising at least one compound of formula I or at least one preferred individual compound as above-defined, or of a fungicidal mixture comprising at least one compound of formula I or at least one preferred individual compound as above-defined, in admixture with other fungicides, as described above, for controlling or preventing infestation of plants, e.g. useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or non-living materials by phytopathogenic microorganisms, preferably fungal organisms.
  • useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or non-living materials by phytopathogenic microorganisms, preferably fungal organisms.
  • a further aspect of invention is related to a method of controlling or preventing an infestation of plants, e.g. useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or of non-living materials by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, which comprises the application of a compound of formula I or of a preferred individual compound as above-defined as active ingredient to the plants, to parts of the plants or to the locus thereof, to the propagation material thereof, or to any part of the non-living materials.
  • Controlling or preventing means reducing infestation by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, to such a level that an improvement is demonstrated.
  • a preferred method of controlling or preventing an infestation of crop plants by phytopathogenic microorganisms, especially fungal organisms, which comprises the application of a compound of formula I, or an agrochemical composition which contains at least one of said compounds, is foliar application.
  • the frequency of application and the rate of application will depend on the risk of infestation by the corresponding pathogen.
  • the compounds of formula I can also penetrate the plant through the roots via the soil (systemic action) by drenching the locus of the plant with a liquid formulation, or by applying the compounds in solid form to the soil, e.g. in granular form (soil application). In crops of water rice such granulates can be applied to the flooded rice field.
  • the compounds of formula I may also be applied to seeds (coating) by impregnating the seeds or tubers either with a liquid formulation of the fungicide or coating them with a solid formulation.
  • a formulation e.g. a composition containing the compound of formula I, and, if desired, a solid or liquid adjuvant or monomers for encapsulating the compound of formula I, may be prepared in a known manner, typically by intimately mixing and/or grinding the compound with extenders, for example solvents, solid carriers and, optionally, surface active compounds (surfactants).
  • extenders for example solvents, solid carriers and, optionally, surface active compounds (surfactants).
  • the agrochemical formulations and/or compositions will usually contain from 0.1 to 99% by weight, preferably from 0.1 to 95% by weight, of the compound of formula I, 99.9 to 1 % by weight, preferably 99.8 to 5% by weight, of a solid or liquid adjuvant, and from 0 to 25% by weight, preferably from 0.1 to 25% by weight, of a surfactant.
  • Advantageous rates of application are normally from 5g to 2kg of active ingredient (a.i.) per hectare (ha), preferably from 10g to 1 kg a.i./ha, most preferably from 20g to 600g a.i./ha.
  • convenient dosages are from 10mg to 1 g of active substance per kg of seeds.
  • Example 1 This example illustrates the preparation of N-(2- ⁇ 1 -[2-(3,5-bis-difluoromethyl- pyrazol-1-yl)-acetyl]-piperidin-4-yl ⁇ -thiazol-4-yl)-3-chloro-2-hydroxy-benzamide (Compound No. I.g.006) a) Preparation of 4-(4-hydroxycarbamoyl-thiazol-2-yl)-piperidine-1-carboxylic acid tert- butyl ester
  • Table 1 illustrates examples of individual compounds of formula I according to the invention.
  • LC/MS Liquid Chromatography Mass Spectroscopy and the description of the apparatus and the method is: (ACQUITY UPLC from Waters,
  • Tomato leaf disks are placed on water agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water.
  • the leaf disks are inoculated with a spore suspension of the fungus 1 day after application.
  • the inoculated leaf disks are incubated at 16°C and 75% rh under a light regime of 24 h darkness followed by 12 h light / 12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf disks (5 - 7 days after application).
  • Compound l.g.006 at 200 ppm gives at least 80% disease control in this test when compared to untreated control leaf discs under the same conditions, which show extensive disease development.
  • 2-week old potato plants cv. Bintje are sprayed in a spray chamber with the formulated test compound diluted in water.
  • the test plants are inoculated by spraying them with a sporangia suspension 2 days after application.
  • the inoculated test plants are incubated at 18° C with 14 h light/day and 100 % rh in a growth chamber and the percentage leaf area covered by disease is assessed when an appropriate level of disease appears on untreated check plants (5 - 7 days after application).
  • Compound l.g.006 at 200 ppm gives at least 80% disease control in this test when compared to untreated control plants under the same conditions, which show extensive disease development.
  • 2-week old potato plants cv. Bintje are sprayed in a spray chamber with the formulated test compound diluted in water.
  • the test plants are inoculated by spraying them with a sporangia suspension 6 days after application.
  • the inoculated test plants are incubated at 18° C with 14 h light/day and 100 % rh in a growth chamber and the percentage leaf area covered by disease is assessed when an appropriate level of disease appears on untreated check plants (9 - 1 1 days after application).
  • Compound l.g.006 at 200 ppm gives at least 80% disease control in this test when compared to untreated control plants under the same conditions, which show extensive disease development.
  • 2-week old potato plants cv. Bintje are inoculated by spraying them with a sporangia suspension one day before application.
  • the inoculated plants are sprayed in a spray chamber with the formulated test compound diluted in water.
  • the inoculated test plants are incubated at 18° C with 14 h light/day and 100 % rh in a growth chamber and the percentage leaf area covered by disease is assessed when an appropriate level of disease appears on untreated check plants (3 - 4 days after application).
  • Grape vine leaf disks are placed on water agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water.
  • the leaf disks are inoculated with a spore suspension of the fungus 1 day after application.
  • the inoculated leaf disks are incubated at 19°C and 80% rh under a light regime of 12 h light / 12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf disks (6 - 8 days after application).
  • 5-week old grape seedlings cv. Gutedel are sprayed in a spray chamber with the formulated test compound diluted in water.
  • the test plants plants are inoculated by spraying a sporangia suspension on their lower leaf surface one day after application.
  • the inoculated test plants are incubated at 22° C and 100% rh in a greenhouse and the percentage leaf area covered by disease is assessed when an appropriate level of disease appears on untreated check plants (6 - 8 days after application).
  • Compound l.g.006 at 200 ppm gives at least 80% disease control in this test when compared to untreated control plants under the same conditions, which show extensive disease development.
  • 5-week old grape seedlings cv. Gutedel are sprayed in a spray chamber with the formulated test compound diluted in water.
  • the test plants are inoculated by spraying a sporangia suspension on their lower leaf surface 6 days after application.
  • the inoculated test plants are incubated at 22° C and 100% rh in a greenhouse and the percentage leaf area covered by disease is assessed when an appropriate level of disease appears on untreated check plants (1 1 - 13 days after application).
  • 5-week-old grape seedlings cv. Gutedel are inoculated by spraying a sporangia suspension on their lower leaf surface one day before application.
  • the inoculated grape plants are sprayed in a spray chamber with the formulated test compound diluted in water.
  • the inoculated test plants are incubated at 22° C and 100% rh in a greenhouse and the percentage leaf area covered by disease is assessed when an appropriate level of disease appears on untreated check plants (4 - 6 days after application).
  • Mycelia fragments and oospores of a newly grown liquid culture of the fungus are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal mycelia/spore mixture is added. The test plates are incubated at 24°C and the inhibition of growth is determined photometrically 2-3 days after application.
  • DMSO DMSO
  • Compound l.g.006 at 200 ppm gives at least 80% disease control in this test when compared to untreated control culture under the same conditions, which show extensive disease development.
  • the test is carried out in plastic containers (650 ml volume) using a mixture of (50%
  • 10 seeds (cotton, cv. Sure Grow 747) are sown in 2 rows of 5 seeds per container (3 replicates for evaluation of the activity, 3 replicates for evaluation of phytotox).
  • Application is carried out directly after sowing by pouring 10 ml compound diluted in water per row over the seeds. Just afterwards the seeds are covered with a thin layer of the same soil and the inoculation is happening.
  • Pythium ultimum is cultivated for 14 days on carrot slices in Roux bottles. For inoculation, the content of the Roux bottles is mixed and homogenously dispensed over the plastic containers without further filtering (70ml suspension per container). Incubation conditions: 20°C, 12h/12h day/night period in the greenhouse. The activity of a compound is assessed as percent disease control relative to untreated check plants when an appropriate level of disease damage appears in untreated check plants (13 - 16 days after application).
  • Compound l.g.006 at 200 ppm gives at least 80% disease control in this test when compared to untreated control plants under the same conditions, which show extensive disease development.

Abstract

The present invention relates to heterocyclic compounds of formula (I) which have microbiocidal activity, in particular fungicidal activity, as well as methods of using the compounds of formula I to control microbes: formula (I) wherein A is x-C(=O)-, x-C(=S)-, x-C(R10R11)-C(=O)-, x-C(R12R13)-C(=S)-, x-O-C(=O)-, x-O-C(=S)-, x-N(R14)-C(=O)-, x-N(R15)-C(=S)-, x-C(R16R17)-SO2- or x-N=C(R26)-, in each case x indicates the bond that is connected to R1; T is CR18 or N; G is O or S; Y1 and Y2 are independently CR19 or N; Q is -C(=O)-z, -C(=S)-z, -C(=O)-O-z, -C(=S)-O-z, -C(=O)-N(R20)-z, -C(=S)-N(R21)-z or -SO2- z-, in each case z indicates the bond that is connected to R9; n is 1 or 2; p is 1 or 2, providing that when n is 2, p is 1; R1 is formula (IA) R2, R3, R4, R5, R6, R7, R10, R11, R12, R13, R16, R17, R18, R19 and R26 each independently are hydrogen, halogen, cyano, C1-C4alkyl or C1-C4haloalkyl; R8, R14, R15, R20 and R21 each independently are hydrogen, C1-C4alkyl or C1-C4alkoxy; and R9 is phenyl, benzyl or group (a), wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, halogen, cyano, hydroxyl, N(R27)2, SH, C1-C4 alkylthio, nitro, phenylsulfonyl and phenylsulfinyl, wherein the phenylsulfonyl and phenylsulfinyl are optionally substituted by 1 to 3 substituents independently selected from C1-C4 alkyl, C1-C4haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, halogen and cyano; each R27 independently is hydrogen, C1-C4 alkyl, phenylsulfonyl or phenylsulfinyl, wherein the phenylsulfonyl and phenylsulfinyl are optionally substituted by 1 to 3 substituents independently selected from C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, halogen and cyano; or a salt or a N-oxide thereof.

Description

Microbiocidal Heterocycles
The present invention relates to heterocycles, e.g. as active ingredients, which have microbiocidal activity, in particular fungicidal activity. The invention also relates to preparation of these heterocycles, to heterocyclic derivatives used as intermediates in the preparation of these heterocycles, to preparation of these intermediates, to agrochemical compositions which comprise at least one of the heterocycles, to preparation of these compositions and to use of the heterocycles or compositions in agriculture or horticulture for controlling or preventing infestation of plants, harvested food crops, seeds or non-living materials by phytopathogenic microorganisms, preferably fungi.
Certain heterocycles for use as fungicides are described in WO201 1/018401.
Because the ecological and economical requirements of modern crop protection agents are steadily changing, there is a continuing need for the discvovery and
development of novel fungicides with advanced properties compared to the known products. Surprisingly, it has now been found that the described bis(difluoromethyl)pyrazol derivatives have, for practical purposes, a very advantageous level of biological activity for protecting plants against diseases that are caused by fungi.
The present invention provides compounds of formula I:
Figure imgf000002_0001
wherein
A is x-C(=0)-, x-C(=S)-, x-C(R1V1)-C(=0)-, x-C(R1 R13)-C(=S)-, x-0-C(=0)-, x-0-C(=S)-, x-N(R14)-C(=0)-, x-N(R15)-C(=S)-, x-C(R16R17)-S02- or x-N=C(R26)-, in each case x indicates the bond that is connected to R1 ;
T is CR18 or N;
G is O or S;
Y1 and Y2 are independently CR19 or N;
Q is -C(=0)-z, -C(=S)-z, -C(=0)-0-z, -C(=S)-0-z, -C(=O)-N(R20)-z, -C(=S)-N(R21)-z or -S02-
Z-, in each case z indicates the bond that is connected to R9;
n is 1 or 2;
p is 1 or 2, providing that when n is 2, p is 1 ;
Figure imgf000003_0001
R2, R3, R4, R5, R6, R7, R10- R11- R12' R13' R16' R17' R18' R19 and R26 each independently are hydrogen, halogen, cyano, C1-C4alkyl or C1-C4haioaikyl;
R8, R14, R15, R20 and R21 each independently are hydrogen, C-|-C4alkyl or C-|-C4alkoxy; and R9 is henyl, benzyl or group (a):
Figure imgf000003_0002
(a)
wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C C alkyl, C C haloalkyi, C C alkoxy, C C haloalkoxy, halogen, cyano, hydroxyl, N(R27)2, SH, Ci-C alkylthio, nitro, phenylsulfonyl and phenylsulfinyl, wherein the phenylsulfonyl and phenylsulfinyl are optionally substituted by 1 to 3 substituents independently selected from Ci-C alkyl, C C haloalkyi, Ci-C alkoxy, Ci- C haloalkoxy, halogen and cyano;
each R27 independently is hydrogen, d-C alkyl, phenylsulfonyl or phenylsulfinyl, wherein the phenylsulfonyl and phenylsulfinyl are optionally substituted by 1 to 3 substituents independently selected from C C alkyl, C C haloalkyi, C C alkoxy, C C haloalkoxy, halogen and cyano; or a salt or a N-oxide thereof.
Where substituents are indicated as being optionally substituted, this means that they may or may not carry one or more identical or different substituents. Normally not more than three such optional substituents are present at the same time.
The term "halogen" refers to fluorine, chlorine, bromine or iodine, preferably fluorine, chlorine or bromine.
The term "amino" refers to -NH2.
Alkyl substituents may be straight-chained or branched. Alkyl on its own or as part of another substituent is, depending upon the number of carbon atoms mentioned, for example, methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl and the isomers thereof, for example, iso-propyl, iso-butyl, sec-butyl, tert-butyl, iso-amyl or pivaloyl.
A haloalkyi group may contain one or more identical or different halogen atoms and, for example, may stand for CH2CI, CHCI2, CCI3, CH2F, CHF2, CF3, CF3CH2, CH3CF2, CF3CF2 or CCI3CCI2. The presence of one or more possible asymmetric carbon atoms in a compound of formula I means that the compounds may occur in optically isomeric forms, i.e.
enantiomeric or diastereomeric forms. As a result of the presence of a possible aliphatic C=C double bond, geometric isomerism may occur, .i.e. cis-trans or (E)-(Z) isomerism. Also atropisomers may occur as a result of restricted rotation about a single bond. Formula I is intended to include all those possible isomeric forms and mixtures thereof. The present invention includes all those possible isomeric forms and mixtures thereof for a compound of formula I. Likewise, formula I is intended to include all possible tautomers. The present invention includes all possible tautomeric forms for a compound of formula I.
In each case, the compounds of formula I according to the invention are in free form, in oxidized form as a N-oxide or in salt form, e.g. an agronomically usable salt form.
N-oxides are oxidized forms of tertiary amines or oxidized forms of nitrogen containing heteroaromatic compounds. They are described for instance in the book "Heterocyclic N- oxides" by A. Albini and S. Pietra, CRC Press, Boca Raton 1991.
Suitable salts of the compounds of formula I include those resulting after addition of acid such as those with an inorganic mineral acid e.g. hydrochloric, hydrobromic, sulphuric, nitric or phosphoric acid, or an organic carboxylic acid e.g. oxalic, tartaric, lactic, butyric, toluic, hexanoic or phthalic acid, or a sulfonic acid e.g. methane, benzene or toluene sulfonic acid.
Preferably the compound of formula I is a compound wherein:
A is x-C(=0)-, x-C(=S)-, x-C(R10R11)-C(=O)-, x-C(R12R13)-C(=S)-, x-0-C(=0)-, x-0-C(=S)-, x-N(R14)-C(=0)-, x-N(R15)-C(=S)- or x-C(R16R17)-S02-, in each case x indicates the bond that is connected to R1;
T is CR18 or N;
G is O or S;
Y1 and Y2 are independently CR19 or N;
Q is -C(=0)-z, -C(=S)-z, -C(=0)-0-z, -C(=S)-0-z, -C(=O)-N(R20)-z, -C(=S)-N(R21)-z or -S02- Z-, in each case z indicates the bond that is connected to R9;
n is 1 or 2;
p is 1 or 2, providing that when n is 2, p is 1 ;
R2, R3, R4, R5, R6, R7, R10, R11, R12, R13, R16, R17, R18 and R19 each independently are hydrogen, halogen, cyano, CrC4alkyl, or Ci-C4haloalkyl;
R8, R14, R15, R20 and R21 each independently are hydrogen or C C4alkyl; and
R9 is phenyl, benzyl or group (a):
Figure imgf000005_0001
(a)
wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C-|-C4 alkyl, C-|-C4 haloalkyi, halogen, cyano, hydroxy and amino;
Preferably the compound of formula I is a compound wherein:
A is x-C(=0)-, x-C(=S)-, x-C(R10R11)-C(=O)-, x-C(R12R13)-C(=S)-, x-0-C(=0)-, x-0-C(=S)- or x-C(R16R17)-S02-, in each case x indicates the bond that is connected to R1;
T is CR18 or N;
G is O or S;
Y1 is N;
Y2 is CR19 or N;
Q is -C(=0)-z, -C(=S)-z, -C(=0)-0-z, -C(=S)-0-z, -C(=O)-N(R20)-z, -C(=S)-N(R21)-z or -S02- Z-, in each case z indicates the bond that is connected to R9;
n is 1 or 2;
p is 1 ;
R2, R3, R4, R5, R6, R7, R10, R11, R12, R13, R16, R17, R18 and R19 each independently are hydrogen, halogen, d-C4alkyl, Ci-C4haloalkyl;
R8, R20 and R21 each independently are hydrogen or CrC4alkyl; and
R9 is henyl, benzyl or group (a):
Figure imgf000005_0002
(a)
wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C-|-C4 alkyl, C-|-C4 haloalkyi, halogen, cyano, hydroxy, and amino.
Preferably the compound of formula I is a compound wherein:
A is x-C(=0)-, -x-CR10R11-C(=O)-, x-0-C(=0)- or x-C(R16R17)-S02-, in each case x indicates the bond that is connected to R1 ;
T is CR18 or N;
G is S;
Y1 is N;
Y2 is CR19 or N; Q is -C(=0)-z, -C(=0)-0-z, -C(=O)-N(R20)-z or -S02-z-, in each case z being the bond to R9; n is 1 or 2;
p is 1 ;
R8 and R20 each independently are hydrogen or methyl; and
R9 is henyl, benzyl or group (a):
Figure imgf000006_0001
(a)
wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C1-C4 alkyl, C C4 haloalkyi, hydroxy and halogen.
Preferably the compound of formula I is a compound wherein:
A is x-C(=0)-, x-CH2-C(=0)-, x-0-C(=0)- or x-CH2-S02-, in each case x indicates the bond that is connected to R1;
T is CH or N;
G is S;
Y1 is N;
Y2 is CH or N;
Q is -C(=0)-z, -C(=0)-0-z, -C(=0)-NH-z or -S02-z-, in each case z indicates the bond that is connected to R9;
n is 1 or 2;
p is 1 ;
R2, R3, R4, R5, R6 and R7 are each hydrogen;
R8 is hydrogen; and
R9 is henyl, benzyl or group (a):
Figure imgf000006_0002
(a)
wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C C4 alkyl, C C4 haloalkyi, hydroxy and halogen.
Preferably the compound of formula I is a compound wherein:
A is x-CH2-C(=0)- wherein x indicates the bond that is connected to R1;
T is CH;
G is S;
Y1 is N; Y2 is CH;
Q is -C(=0)-z, -C(=0)-0-z or C(=O)-N(R20)-z, in each case z indicates the bond that is connected to R9;
n is 2;
p is 1 ;
R2, R3, R4, R5, R6, and R7 are each hydrogen;
R8, is hydrogen;
R9 is henyl, benzyl or group (a):
Figure imgf000007_0001
(a)
wherein the phenyl, benzyl and group (a) are optionally substituted with 1 to 3 substituents independently selected from halogen, hydroxy, methyl and halomethyl.
The invention also provides a compound of formula I in which:
A is x-CH2C(=0)-, x-CH2C(=S)-, x-OC(=0)-, x-C(=0)- or x-CH2-S02-, in each case x indicates the bond that is connected to R1;
T is CH or N;
G is O or S;
Y1 is N;
Y2 is CH or N;
Q is -C(=0)-z, -C(=S)-z, -C(=0)0-z, -C(=0)NH-z or -S02-z, in each case z indicates the bond that is connected to R9;
n is 1 or 2;
p is 1 or 2, providing that when n is 2, p is 1 ;
R2, R3, R4, R5, R6 and R7 are H;
R8 is H or methyl;
R9 is roup (i), Q), (k), (I) or (m):
Figure imgf000007_0002
(i) G) (k) (I) (m)
The following list provides definitions, including preferred definitions, for substituents A, T, G, Y1, Y2, Q, n, p, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, R18, R19, R20, R21 , R26 and R27 with reference to compounds of formula I. For any one of these substituents, any of the definitions given below may be combined with any definition of any other substituent given below or elsewhere in this document. The invention includes compounds of formula having all possible combinations of substituent definitions given below. Generally, in this document any substituent definition may be combined with any other substituent definition.
A is x-C(=0)-, x-C(=S)-, x-C(R10R11)-C(=O)-, x-C(R12R13)-C(=S)-, x-0-C(=0)-, x-O-
C(=S)-, x-N(R14)-C(=0)-, x-N(R15)-C(=S)-, x-C(R16R17)-S02- or x-N=C(R26)-, in each case x indicates the bond that is connected to R1. Preferably A is x-C(=0)-, x-C(=S)-, x-C(R10R11)- C(=0)-, x-C(R12R13)-C(=S)-, x-0-C(=0)-, x-0-C(=S)-, x-N(R14)-C(=0)-, x-N(R15)-C(=S)-or x- C(R16R17)-S02-, in each case x indicates the bond that is connected to R1. More preferably, A is x-C(=0)-, x-C(=S)-, x-C(R10R11)-C(=O)-, x-C(R12R13)-C(=S)-, x-0-C(=0)-, x-0-C(=S)- or x-C(R16R17)-S02-, in each case x indicates the bond that is connected to R1. Even more preferably, A is x-C(=0)-, -x-CR10R11-C(=O)-, x-0-C(=0)- or x-C(R16R17)-S02-, in each case x indicates the bond that is connected to R1. Yet more preferably, A is x-CH2C(=0)-, x- CH2C(=S)-, x-OC(=0)-, x-C(=0)- or x-CH2-S02-, in each case x indicates the bond that is connected to R1. Most preferably, A is x-CH2-C(=0)- wherein x indicates the bond that is connected to R1.
T is CR18 or N. Preferably, T is CH or N. More preferably, T is CH.
G is O or S. Preferably, G is S.
Y1 is CR19 or N. Preferably, Y1 is N.
Y2 is CR19 or N. Preferably, Y2 is CH or N. More preferably, Y2 is CH.
Q is -C(=0)-z, -C(=S)-z, -C(=0)-0-z, -C(=S)-0-z, -C(=O)-N(R20)-z, -C(=S)-N(R21)-z or -S02-z-, in each case z indicates the bond that is connected to R9. Preferably, Q is -C(=0)- z, -C(=S)-z, -C(=0)0-z, -C(=0)NH-z or -S02-z, in each case z indicates the bond that is connected to R9. Preferably, Q is -C(=0)-z, -C(=0)-0-z, -C(=O)-N(R20)-z or -S02-z-, in each case z indicates the bond that is connected to R9. More preferably, Q is -C(=0)-z, -C(=0)- O-z, -C(=0)-NH-z or -S02-z-, in each case z indicates the bond that is connected to R9. Even more preferably, Q is Q is -C(=0)-z, -C(=0)-0-z or C(=O)-N(R20)-z, in each case z indicates the bond that is connected to R9. Most preferably Q is -C(=0)-z wherein z indicates the bond that is connected to R9.
n is 1 or 2. Preferably, n is 2.
p is 1 or 2, providing that when n is 2, p is 1 . Preferably p is 1.
R2, R3, R4, R5, R6, R7, R10, R11, R12, R13, R16, R17, R18, R19 each independently are hydrogen, halogen, cyano, C C4alkyl, or Ci-C4haloalkyl. Preferably, R2, R3, R4, R5, R6, R7, R10, R11 , R12, R13, R16, R17, R18 and R19 each independently are hydrogen, halogen, C C4alkyl, or C C4haloalkyl. More preferably, R2, R3, R4, R5, R6, R7, R10, R11 , R12, R13, R16, R17, R18 and R19 each independently are hydrogen, fluoro, or methyl. Even more preferably, R2, R3, R4, R5, R6, R7, R10, R11 , R12, R13, R16, R17, R18 and R19 each independently are hydrogen.
R8, R14, R15, R20, and R21 each independently are hydrogen or d-C4alkyl. Preferably, R8, R14, R15, R20, and R21 each independently are hydrogen or methyl.
More preferably, R8, R14, R15, R20, and R21 each independently are hydrogen.
R9 is henyl, benzyl or group (a):
Figure imgf000009_0001
(a)
wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C1-C4 alkyl, C1-C4 haloalkyi, C1-C4 alkoxy, Ci-C4 haloalkoxy, halogen, cyano, hydroxyl, N(R27)2, SH, C-|-C4 alkylthio, nitro, phenylsulfonyl and phenylsulfinyl, wherein the phenylsulfonyl and phenylsulfinyl are optionally substituted by 1 to 3 substituents independently selected from C1-C4 alkyl, C1-C4 haloalkyi, C1-C4 alkoxy, Ci- C4 haloalkoxy, halogen and cyano. Preferably, R9 is phenyl, benzyl or group (a):
Figure imgf000009_0002
(a)
wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C1-C4 alkyl, C1-C4 haloalkyi, halogen, cyano, h droxy and amino. Preferably, R9 is phenyl, benzyl or group (a):
Figure imgf000009_0003
(a)
wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C-|-C4 alkyl, C-|-C4 haloalkyi, hydroxy and halogen. More referably, R9 is phenyl, benzyl or group (a):
Figure imgf000009_0004
(a) wherein the phenyl, benzyl and group (a) are optionally substituted with 1 to 3 substituents independently selected from halogen, hydroxy, methyl and halomethyl.
R26 is hydrogen, halogen, cyano, CrC4alkyl, or Ci-C4haloalkyl. Preferably, R26 is hydrogen, halogen, Ci-C4alkyl, or Ci-C4haloalkyl. Preferably, R26 is hydrogen, fluoro, or methyl. More preferably, R26 is hydrogen.
Each R27 independently is hydrogen, d-C4 alkyl, phenylsulfonyl or phenylsulfinyl, wherein the phenylsulfonyl and phenylsulfinyl are optionally substituted by 1 to 3
substituents independently selected from C C4 alkyl, C C4 haloalkyl, C C4 alkoxy, C C4 haloalkoxy, halogen and cyano. Preferably, R27 is independently is hydrogen, Ci-C4 alkyl, phenylsulfonyl or phenylsulfinyl, wherein the phenylsulfonyl and phenylsulfinyl are optionally substituted by 1 to 3 substituents independently selected from halogen, methyl and halomethyl.
In one roup of compounds R9 is group (i), (j), (k), (I) or (m):
Figure imgf000010_0001
(i) G) (k) (I) (m)
In one group of compounds G is S, Y1 is N and Y2 is CH.
In one group of compounds p is 1 and n is 2.
In one group of compounds R2, R3, R4, R5, R6 and R7 are H.
In one group of compounds Q is -C(=0)-z, wherein z indicates the bond that is connected to R9.
In one group of compounds A is x-CH2-C(=0)-, wherein x indicates the bond that is connected to R1.
In one group of compounds R9 is phenyl substituted by hydroxyl, and optionally substituted by one or two further substituents as defined above. Preferably the hydroxy is at the ortho position. Preferably one of the further substituents is halogen and is preferably at the meta position adjacent to the hydroxy.
For the avoidance of doubt, when n is 1 and p is 1 compounds of formula I have the formula according to formula IA:
Figure imgf000010_0002
in which A, T, G, Y1 , Y2, Q, R1 , R2, R3, R4, R5, R6, R7, R8, and R9 have the definitions as described for formula I. When n is 2 and p is 1 , compounds of formula I have the formula according to formula
IB:
Figure imgf000011_0001
in which A, T, G, Y1 , Y2, Q, R1 , R2, R3, R4, R5, R6, R7, R8, and R9 have the definitions as described for formula I.
When n is 1 and p is 2, compounds of formula I have the formula according to formula
I
Figure imgf000011_0002
in which A, T, G, Y1 , Y2, Q, R1 , R2, R3, R4, R5, R6, R7, R8, and R9 have the definitions as described for formula I.
The invention also relates to compounds of formula IA, formula IB and formula IC as shown above.
ula ID:
Figure imgf000011_0003
in which A, G, Y1, Y2, Q, R1, R2, R3, R4, R5, R6, R7, R8, and R9 have the definitions as described for formula I. Preferred definitions of A, G, Y1 , Y2, Q, R1 , R2, R3, R4, R5, R6, R7, R8, and R9 are as defined for formula I.
The invention also relates to compounds of formula IE:
Figure imgf000011_0004
in which A, Q, R1 , R2, R3, R4, R5, R6, R7, R8, and R9 have the definitions as described for formula I. Preferred definitions of A, Q, R1 , R2, R3, R4, R5, R6, R7, R8, and R9 are as defined for formula I.
The invention also relates to compounds of formula IF:
Figure imgf000012_0001
wherein T is CH or N
R8 is CH3 or H; and
R1 and R9 have the definitions as described for formula I. Preferred definitions of R1 and R9 are as defined for formula I.
The invention also relates to compounds of formula IG:
Figure imgf000012_0002
wherein T is CH or N
R8 is CH3 or H; and
R9 has the definition as described for formula I. Preferred definitions of R9 are as defined for formula I.
The invention also includes compounds of formula II:
Figure imgf000012_0003
wherein R1 , R2, R3, R4, R5, R6, R7, R8, A, T, G, Y1 , Y2 , p and n are as defined for formula I. Preferred definitions of R1, R2, R3, R4, R5, R6, R7, R8, A, T, G, Y1, Y2 , p and n are as defined for formula I. Compounds of formula II are useful as intermediates in the synthesis of compounds of formula I.
The invention also includes compounds of formula VIII:
Figure imgf000013_0001
wherein R1 , R2, R3, R4, R6, R7, R8, A, T, G, Y1 , Y2 , p and n are as defined for formula I. Preferred definitions of R1 , R2, R3, R4, R6, R7, R8, A, T, G, Y1 , Y2 , p and n are as defined for formula I. Compounds of formula VII I are useful as intermediates in the synthesis of compounds of formula I .
Compounds of formula (I) can be made in an analogous way to those described in WO201 1 /018401 and as shown in the following schemes.
The compounds of formula I, wherein R1 , R2, R3, R4, R5, R6, R7 , R8, R9, A, T, G, Y1 , Y2, n, p and Q are as defined for formula I can be obtained by transformation of a compound of formula I I , wherein R1 , R2, R3, R4, R5, R6, R7, R8, A, T, G, Y1 , Y2, n, p and Y are as defined for formula I with a compound of formula I I I, wherein R9 and Q are as defined for formula I and X is a hydroxy, halogen, preferably fluoro, chloro or bromo or alkoxy, such as methoxy, ethoxy. This is shown in Scheme 1 .
Scheme 1
Figure imgf000013_0002
The compounds of formula 11.1 , wherein R1 , R2, R3, R4, R5, R6, R7, A, T, G, n, p, Y1 and Y2 are as defined for formula I , can be obtained by transformation of a compound of formula IV, wherein R1 , R2, R3, R4, R5, R6, R7, A, T, G, n, p, Y1 and Y2 are as defined for formula I with an azide, such as diphenyl phosphoryl azide and subsequent Curtius rearrangement of the resulting acyl azide with an alcohol R28-OH, wherein R28 is Ci-C6alkyl or optionally substituted aryl and following carbamate cleavage with a mineral acid, such as hydrochloric acid, sulfuric acid or an organic acid, such as trifluoroacetic acid. This is shown in Scheme 2.
Scheme 2
1. DPPA, R28-OH
2. deprotection
or
1. i) CDI
Figure imgf000014_0001
The compounds of formula IV, wherein R1 , R2, R3, R4, R5, R6, R7, A, T, G, n, p, Y1 and Y2 are as defined for formula I can be obtained by saponification of a compound of formula V, wherein R1 , R2, R3, R4, R5, R6, R7, A, T, G, n, p, Y1 and Y2 are as defined for formula I and R28 is CrC6alkyl or optionally substituted aryl with a base, such as sodium hydroxide, potassium hydroxide or lithium hydroxide. This is shown in Scheme 3.
Scheme 3
Figure imgf000014_0002
The compounds of formula V, wherein R1, R2, R3, R4, R5, R6, R7, A, T, G, n, p, Y1 and Y2 are as defined for formula I and R28 is C-|-C6alkyl or optionally substituted aryl can be obtained by transformation of a compound of formula VI, wherein R2, R3, R4, R5, R6, R7, T, G, n, p, Y1 and Y2 are as defined for formula I and R28 is C Cealkyl or optionally substituted aryl with a compound of formula VII, wherein R1 and A are as defined for formula I and X is a hydroxy, halogen, preferably fluoro, chloro or bromo or alkoxy, such as methoxy, ethoxy. This is shown in Scheme 4. Scheme 4
Figure imgf000015_0001
Alternatively, the compounds of formula 1.1 , wherein R1, R2, R3, R4, R5, R6, R7, R9, A, T, G, n, Y1 and Y2 are as defined for formula I and R29 is Ci-C6alkyl can be obtained by transformation of a compound of formula 1.2, wherein R1, R2, R3, R4, R5, R6, R7, R9, A, T, G, n, Y1 and Y2 are as defined for formula I with an alkyl halide R29-Hal, wherein R29 is C C6alkyl and Hal is halogen, preferably chloro or bromo. This is shown in Scheme 5.
Scheme 5
Figure imgf000015_0002
The compounds of formula I.2, wherein R1, R2, R3, R4, R5, R6, R7, R9, A, T, G, n, p, Y1 and Y2 are as defined for formula I can be obtained by transformation of a compound of formula IV, wherein R1, R2, R3, R4, R5, R6, R7, A, T, G, n, p, Y1 and Y2 are as defined for formula I with an azide, such as diphenyl phosphoryl azide and subsequent Curtius rearrangement of the resulting acyl azide with a Grignard reagent R9-Mg-Hal, wherein R9 is as defined for formula I and Hal is halogen, preferably chloro, bromo or iodo, or a boronic acid R9-B(OH)2, wherein R9 is as defined for formula I and a catalyst, such as bis(1 ,5- cyclooctadiene)rhodium(l) hydroxide. This is shown in Scheme 6. Scheme 6
Figure imgf000016_0001
Alternatively, the compounds of formula 1.3, wherein R1, R2, R3, R4, R5, R6, R7, R9, A, T, G, n, p, Y1 and Y2 are as defined for formula I and R29 is CrC6alkyl can be obtained by transformation of a compound of formula 1.4, wherein R1, R2, R3, R4, R5, R6, R7, R9, A, T, G, n, p, Y1 and Y2 are as defined for formula I with an alkyl halide R29-Hal, wherein R29 is C C6alkyl and Hal is halogen, preferably chloro or bromo. This is shown in Scheme 7.
Scheme 7
Figure imgf000016_0002
The compounds of formula I.4, wherein R1, R2, R3, R4, R5, R6, R7, R9, A, T, G, n, p, Y1 and Y2 are as defined for formula I can be obtained by transformation of a compound of formula IV, wherein R1, R2, R3, R4, R5, R6, R7, A, T, G, n, p, Y1 and Y2 are as defined for formula I with an azide, such as diphenyl phosphoryl azide and subsequent Curtius rearrangement of the resulting acyl azide with an alcohol R9-OH, wherein R9 is as defined for formula I as defined for formula I. This is shown in Scheme 8.
Scheme 8
Figure imgf000016_0003
Alternatively, the compounds of formula 1.5, wherein R1, R2, R3, R4, R5, R6, R7, R9, A, T, G, n, Y1 and Y2 are as defined for formula I and R29 is CrC6alkyl can be obtained by transformation of a compound of formula 1.6, wherein R1, R2, R3, R4, R5, R6, R7, R9, A, T, G, n, Y1 and Y2 are as defined for formula I with an alkyl halide R29-Hal, wherein R29 is C C6alkyl and Hal is halogen, preferably chloro or bromo. This is shown in Scheme 9. Scheme 9
Figure imgf000017_0001
The compounds of formula 1.6, wherein R1, R2, R3, R4, R5, R6, R7, R9, A, T, G, n, p, Y1 and Y2 are as defined for formula I can be obtained by transformation of a compound of formula IV, wherein R1, R2, R3, R4, R5, R6, R7, A, T, G, n, p, Y1 and Y2 are as defined for formula I with an azide, such as diphenyl phosphoryl azide and subsequent Curtius rearrangement of the resulting acyl azide with an amine R9-NH2, wherein R9 is as defined for formula I. This is shown in Scheme 10.
Scheme 10
Figure imgf000017_0002
Alternatively, the compounds of formula 1.7, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, A, G, n, p, Y1, Y2 and Q are as defined for formula I, can be obtained by reduction of a compound of formula VIII, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, A, G, n, p, Y1, Y2 and Q are as defined for formula I with hydrogen and a catalyst, such as palladium on charcoal, platinum or raney-nickel. This is shown in Scheme 1 1.
Scheme 1 1
Figure imgf000017_0003
The compounds of formula VIII, wherein R1 , R2, R3, R4, R5, R6, R7, R8, R9, A, G, n, p, Y1, Y2 and Q are as defined for formula I can be obtained by cross coupling of a compound of formula IX, wherein R8, R9, G, Y1, Y2 and Q are as defined for formula I and Hal is halogen, preferably chloro, bromo or iodo with a compound of formula X, wherein R1, R2, R3, R4, R5, R6, R7 and A are as defined for formula I and R30 is B(OH)2 and a transition metal, such as tetrakis(triphenylphosphine)palladium, and a ligand, such as. This is shown in Scheme 12. Scheme 12
Figure imgf000018_0001
catalyst,
ligand
Figure imgf000018_0002
Alternatively, the compounds of formula V.1 , wherein R1 , R2, R3, R4, R5, R6, R7, A, G, n, p, Y1 and Y2 are as defined for formula I and R28 is C-|-C6alkyl or optionally substituted aryl can be obtained by reduction of a compound of formula XI, wherein R1, R2, R3, R4, R5, R6, R7, A, G, n, p, Y1 and Y2 are as defined for formula I and R28 is CrC6alkyl or optionally substituted aryl with hydrogen and a catalyst, such as palladium on charcoal, platinum or raney-nickel. This is shown in Scheme 13.
Scheme 13
Figure imgf000018_0003
The compounds of formula XI, wherein R1, R2, R3, R4, R5, R6, R7, A, G, n, p, Y1 and Y2 are as defined for formula I and R28 is CrC6alkyl or optionally substituted aryl can be obtained by cross coupling of a compound of formula XII, wherein G, Y1 and Y2 are as defined for formula I, R28 is Ci-C6alkyl or optionally substituted aryl and Hal is halogen, preferably chloro, bromo or iodo with a compound of formula XIII, wherein R1, R2, R3, R4, R5, R6, R7 and A are as defined for formula I and R30 is B(OH)2 and a transition metal, such as bis-(triphenylphosphine)palladium(ll) chloride. This is shown in Scheme 14. Scheme 14
Figure imgf000019_0001
catalyst,
ligand
Figure imgf000019_0002
Alternatively, the compounds of formula VIII, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, A, G, n, p, Y1, Y2 and Q are as defined for formula I, can be obtained by cross coupling of a compound of formula XIV, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, A, G, n, p, Y1, and Y2 are as defined for formula I with a compound of formula XV, wherein R8, R9 and Q are as defined for formula I and a ligand such as Xantphos or dimethylethylenediamine and a catalyst, such as Pd(OAc)2 or copperiodide. This is shown in Scheme 15.
Scheme 15
Figure imgf000019_0003
(χν)
The compounds of formula XIV, wherein R1, R2, R3, R4, R5, R6, R7, A, G, n, p, Y1 and Y2 are as defined for formula I can be obtained by cross coupling of a compound of formula XVI, wherein G, Y1 and Y2 are as defined for formula I, with a compound of formula XIII, wherein R1 , R2, R3, R4, R5, R6, R7 and A are as defined for formula I and R30 is B(OH)2 and a transition metal, such as bis-(triphenylphosphine)palladium(ll) chloride. This is shown in Scheme 16. Scheme 16
Figure imgf000020_0001
Surprisingly, it has now been found that the novel compounds of formula I have, for practical purposes, a very advantageous level of biological activity for protecting plants against diseases that are caused by fungi.
The compounds of formula I can be used in the agricultural sector and related fields of use e.g. as active ingredients for controlling plant pests or on non-living materials for control of spoilage microorganisms or organisms potentially harmful to man. The novel compounds are distinguished by excellent activity at low rates of application, by being well tolerated by plants and by being environmentally safe. They have very useful curative, preventive and systemic properties and may be used for protecting numerous cultivated plants. The compounds of formula I can be used to inhibit or destroy the pests that occur on plants or parts of plants (fruit, blossoms, leaves, stems, tubers, roots) of different crops of useful plants, while at the same time protecting also those parts of the plants that grow later e.g. from phytopathogenic microorganisms.
It is also possible to use compounds of formula I as dressing agents for the treatment of plant propagation material, e.g., seed, such as fruits, tubers or grains, or plant cuttings (for example rice), for the protection against fungal infections as well as against
phytopathogenic fungi occurring in the soil. The propagation material can be treated with a composition comprising a compound of formula I before planting: seed, for example, can be dressed before being sown. The active ingredients according to the invention can also be applied to grains (coating), either by impregnating the seeds in a liquid formulation or by coating them with a solid formulation. The composition can also be applied to the planting site when the propagation material is being planted, for example, to the seed furrow during sowing. The invention relates also to such methods of treating plant propagation material and to the plant propagation material so treated.
Furthermore the compounds according to present invention can be used for controlling fungi in related areas, for example in the protection of technical materials, including wood and wood related technical products, in food storage, in hygiene
management.
In addition, the invention could be used to protect non-living materials from fungal attack, e.g. lumber, wall boards and paint.
The compounds of formula I are, for example, effective against the phytopathogenic fungi of the following classes: Fungi imperfecti (e.g. Alternaria spp.), Basidiomycetes (e.g. Corticium spp., Ceratobasidium spp., Waitea spp., Thanatephorus spp., Rhizoctonia spp., Hemileia spp., Puccinia spp., Phakopsora spp., Ustilago spp., Tilletia spp.), Ascomycetes (e.g. Venturia spp., Blumeria spp., Erysiphe spp., Podosphaera spp., Uncinula spp., Monilinia spp., Sclerotinia spp., Colletotrichum spp., Glomerella spp., Fusarium spp., Gibberella spp., Monographella spp., Phaeosphaeria spp., Mycosphaerella spp.,
Cercospora spp., Pyrenophora spp., Rhynchosporium spp., Magnaporthe spp.,
Gaeumannomyces spp., Oculimacula spp., Ramularia spp., Botryotinia spp.) and
Oomycetes (e.g. Phytophthora spp., Pythium spp., Plasmopara spp., Peronospora spp., Pseudoperonospora spp. Bremia spp). Outstanding activity is observed against downy mildew (e.g. Plasmopara viticola) and late blight (e.g. Phytophthora infestans).
Furthermore, the novel compounds of formula I are effective against phytopathogenic gram negative and gram positive bacteria (e.g. Xanthomonas spp, Pseudomonas spp, Erwinia amylovora, Ralstonia spp.) and viruses (e.g. tobacco mosaic virus).
Within the scope of present invention, target crops and/or useful plants to be protected typically comprise the following species of plants: cereal (wheat, barley, rye, oat, rice, maize, sorghum and related species); beet (sugar beet and fodder beet); pomes, drupes and soft fruit (apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries and blackberries); leguminous plants (beans, lentils, peas, soybeans); oil plants (rape, mustard, poppy, olives, sunflowers, coconut, castor oil plants, cocoa beans, groundnuts); cucumber plants (pumpkins, cucumbers, melons); fibre plants (cotton, flax, hemp, jute); citrus fruit (oranges, lemons, grapefruit, mandarins); vegetables (spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, paprika); lauraceae (avocado, cinnamomum, camphor) or plants such as tobacco, nuts, coffee, eggplants, sugar cane, tea, pepper, vines, hops, bananas and natural rubber plants, as well as turf and ornamentals.
The useful plants and / or target crops in accordance with the invention include conventional as well as genetically enhanced or engineered varieties such as, for example, insect resistant (e.g. Bt. and VIP varieties) as well as disease resistant, herbicide tolerant (e.g. glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady® and LibertyLink®) and nematode tolerant varieties. By way of example, suitable genetically enhanced or engineered crop varieties include the
Stoneville 5599BR cotton and Stoneville 4892BR cotton varieties.
The term "useful plants" and/or "target crops" is to be understood as including also useful plants that have been rendered tolerant to herbicides like bromoxynil or classes of herbicides (such as, for example, HPPD inhibitors, ALS inhibitors, for example
primisulfuron, prosulfuron and trifloxysulfuron, EPSPS (5-enol-pyrovyl-shikimate-3- phosphate-synthase) inhibitors, GS (glutamine synthetase) inhibitors or PPO
(protoporphyrinogen-oxidase) inhibitors) as a result of conventional methods of breeding or genetic engineering. An example of a crop that has been rendered tolerant to
imidazolinones, e.g. imazamox, by conventional methods of breeding (mutagenesis) is Clearfield® summer rape (Canola). Examples of crops that have been rendered tolerant to herbicides or classes of herbicides by genetic engineering methods include glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names
RoundupReady® , Herculex I® and LibertyLink®.
The term "useful plants" and/or "target crops" is to be understood as including also useful plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.
The term "useful plants" and/or "target crops" is to be understood as including also useful plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising antipathogenic substances having a selective action, such as, for example, the so-called "pathogenesis-related proteins" (PRPs, see e.g. EP-A-0 392 225). Examples of such antipathogenic substances and transgenic plants capable of synthesising such antipathogenic substances are known, for example, from EP-A-0 392 225, WO 95/33818, and EP-A-0 353 191. The methods of producing such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above.
The term "locus" of a plant as used herein is intended to embrace the place on which the plants are growing, where the plant propagation materials of the plants are sown or where the plant propagation materials of the plants will be placed into the soil. An example for such a locus is a field, on which crop plants are growing.
The term "plant propagation material" is understood to denote generative parts of the plant, such as seeds, which can be used for the multiplication of the latter, and vegetative material, such as cuttings or tubers, for example potatoes. There may be mentioned for example seeds (in the strict sense), roots, fruits, tubers, bulbs, rhizomes and parts of plants. Germinated plants and young plants which are to be transplanted after germination or after emergence from the soil, may also be mentioned. These young plants may be protected before transplantation by a total or partial treatment by immersion. Preferably "plant propagation material" is understood to denote seeds.
The compounds of formula I may be used in unmodified form or, preferably, together with the adjuvants conventionally employed in the art of formulation. To this end they may be conveniently formulated in known manner to emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions or suspensions, dilute emulsions, wettable powders, soluble powders, dusts, granulates, and also encapsulations e.g. in polymeric substances. As with the type of the compositions, the methods of application, such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances. The compositions may also contain further adjuvants such as stabilizers, antifoams, viscosity regulators, binders or tackifiers as well as fertilizers, micronutrient donors or other formulations for obtaining special effects.
Suitable carriers and adjuvants, e.g. for agricultural use, can be solid or liquid and are substances useful in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers. Such carriers are for example described in WO 97/33890.
The compounds of formula I are normally used in the form of compositions and can be applied to the crop area or plant to be treated, simultaneously or in succession with further compounds. These further compounds can be e.g. fertilizers or micronutrient donors or other preparations, which influence the growth of plants. They can also be selective herbicides or non-selective herbicides as well as insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of these preparations, if desired together with further carriers, surfactants or application promoting adjuvants customarily employed in the art of formulation.
The compounds of formula I may be used in the form of fungicidal compositions for controlling or protecting against phytopathogenic microorganisms, comprising as active ingredient at least one compound of formula I or of at least one preferred individual compound as above-defined, in free form or in agrochemically usable salt form, and at least one of the above-mentioned adjuvants.
The invention provides a fungicidal composition comprising at least one compound formula I an agriculturally acceptable carrier and optionally an adjuvant. An agricultural acceptable carrier is for example a carrier that is suitable for agricultural use. Agricultural carriers are well known in the art. Preferably said fungicidal compositions may comprise an additional fungicidal active ingredient in addition to the compound of formula I. The compound of formula (I) may be the sole active ingredient of a composition or it may be admixed with one or more additional active ingredients such as an insecticide, fungicide, synergist, herbicide or plant growth regulator where appropriate. An additional active ingredient may, in some cases, result in unexpected synergistic activities. Examples of suitable additional active ingredients include the following: Azoxystrobin (131860-33-8), Dimoxystrobin (149961-52-4), Enestrobin (238410-1 1 -2), Fluoxastrobin (193740-76-0), Kresoxim-methyl (143390-89-0), Metominostrobin (133408-50-1 ), Orysastrobin (248593-16- 0), Picoxystrobin (1 17428-22-5), Pyraclostrobin (175013-18-0), Azaconazole (60207-31-0), Bromuconazole (1 16255-48-2), Cyproconazole (94361 -06-5), Difenoconazole (1 19446-68- 3), Diniconazole (83657-24-3), Diniconazole-M (83657-18-5), Epoxiconazole (13385-98-8), Fenbuconazole (1 14369-43-6), Fluquinconazole (136426-54-5), Flusilazole (85509-19-9), Flutriafol (76674-21-0), Hexaconazole (79983-71-4), Imazalil (58594-72-2), Imibenconazole (86598-92-7), Ipconazole (125225-28-7), Metconazole (1251 16-23-6), Myclobutanil (88671 - 89-0), Oxpoconazole (174212-12-5), Pefurazoate (5801 1-68-0), Penconazole (66246-88-6), Prochloraz (67747-09-5), Propiconazole (60207-90-1 ), Prothioconazole (178928-70-6), Simeconazole (149508-90-7), Tebuconazole (107534-96-3), Tetraconazole (1 12281-77-3), Triadimefon (43121-43-3), Triadimenol (55219-65-3), Triflumizole (99387-89-0),
Triticonazole (131983-72-7), Diclobutrazol (76738-62-0), Etaconazole (60207-93-4), Fluconazole (86386-73-4), Fluconazole-cis (1 12839-32-4), Thiabendazole (148-79-8), Quinconazole (103970-75-8), Fenpiclonil (74738-17-3), Fludioxonil (131341-86-1 ),
Cyprodinil (121552-61 -2), Mepanipyrim (1 10235-47-7), Pyrimethanil (531 12-28-0),
Aldimorph (91315-15-0), Dodemorph (1593-77-7), Fenpropimorph (67564-91-4),
Tridemorph (81412-43-3), Fenpropidin (67306-00-7), Spiroxamine (1 18134-30-8),
Isopyrazam (881685-58-1 ), Sedaxane (874967-67-6), Bixafen (581809-46-3), Penthiopyrad (183675-82-3), Fluxapyroxad (907204-31 -3), Boscalid (188425-85-6), Penflufen (494793- 67-8), Fluopyram (658066-35-4), Mandipropamid (374726-62-2), Benthiavalicarb (413615- 35-7), Dimethomorph (1 10488-70-5), Chlorothalonil (1897-45-6), Fluazinam (79622-59-6), Dithianon (3347-22-6), Metrafenone (220899-03-6), Tricyclazole (41814-78-2), Mefenoxam (70630-17-0), Metalaxyl (57837-19-1 ), Acibenzolar (126448-41-7) (Acibenzolar-S-methyl (126448-41-7)), Mancozeb (8018-01-7), Ametoctradine (865318-97-4) Ipconazole (125225- 28-7), Amisulbrom (348635-87-0), Cyflufenamid (180409-60-3), Ethaboxam (16650-77-3), Fluopicolide (2391 10-15-7), Fluthianil (304900-25-2), Isotianil (224049-04-1 ), Proquinazid (189278-12-4), Valiphenal (283159-90-0), 1-methyl-cyclopropene (3100-04-7),
Trifloxystrobin (141517-21 -7), Sulfur (7704-34-9), Copper ammoniumcarbonate (CAS 331 13-08-5); Copper oleate (CAS 1 120-44-1 ); Folpet (133-07-3), Quinoxyfen (124495-18- 7), Captan (133-06-2), Fenhexamid (126833-17-8), Glufosinate and its salts (51276-47-2, 35597-44-5 (S-isomer)), Glyphosate (1071-83-6 ) and its salts (69254-40-6 (Diammonium), 34494-04-7 (Dimethylammonium), 38641 -94-0 (Isopropylammonium), 40465-66-5
(Monoammonium), 70901 -20-1 (Potassium), 70393-85-0 (Sesquisodium), 81591-81-3 (Trimesium)), 1-methyl-3-difluoromethyl-1 H-pyrazole-4-carboxylic acid (2- dichloromethylene-3-ethyl-1-methyl-indan-4-yl)-amide, 1 -methyl-3-difluoromethyl-1 H- pyrazole-4-carboxylic acid (4'-methylsulfanyl-biphenyl-2-yl)-amide, 1 -methyl-3- difluoromethyl-4H-pyrazole-4-carboxylic acid [2-(2,4-dichloro-phenyl)-2-methoxy-1 -methyl- ethyl]-amide, (5-Chloro-2,4-dimethyl-pyridin-3-yl)-(2,3,4-trimethoxy-6-methyl-phenyl)- methanone, (5-Bromo-4-chloro-2-methoxy-pyridin-3-yl)-(2,3,4-trimethoxy-6-methyl-phenyl)- methanone, 2-{2-[(E)-3-(2,6-Dichloro-phenyl)-1 -methyl-prop-2-en-(E)- ylideneaminooxymethyl]-phenyl}-2-[(Z)-methoxyimino]-N-methyl-acetamide, 3-[5-(4-Chloro- phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine.
Another aspect of invention is related to the use of a compound of formula I or of a preferred individual compound as above-defined, of a composition comprising at least one compound of formula I or at least one preferred individual compound as above-defined, or of a fungicidal mixture comprising at least one compound of formula I or at least one preferred individual compound as above-defined, in admixture with other fungicides, as described above, for controlling or preventing infestation of plants, e.g. useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or non-living materials by phytopathogenic microorganisms, preferably fungal organisms.
A further aspect of invention is related to a method of controlling or preventing an infestation of plants, e.g. useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or of non-living materials by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, which comprises the application of a compound of formula I or of a preferred individual compound as above-defined as active ingredient to the plants, to parts of the plants or to the locus thereof, to the propagation material thereof, or to any part of the non-living materials.
Controlling or preventing means reducing infestation by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, to such a level that an improvement is demonstrated.
A preferred method of controlling or preventing an infestation of crop plants by phytopathogenic microorganisms, especially fungal organisms, which comprises the application of a compound of formula I, or an agrochemical composition which contains at least one of said compounds, is foliar application. The frequency of application and the rate of application will depend on the risk of infestation by the corresponding pathogen.
However, the compounds of formula I can also penetrate the plant through the roots via the soil (systemic action) by drenching the locus of the plant with a liquid formulation, or by applying the compounds in solid form to the soil, e.g. in granular form (soil application). In crops of water rice such granulates can be applied to the flooded rice field. The compounds of formula I may also be applied to seeds (coating) by impregnating the seeds or tubers either with a liquid formulation of the fungicide or coating them with a solid formulation.
A formulation, e.g. a composition containing the compound of formula I, and, if desired, a solid or liquid adjuvant or monomers for encapsulating the compound of formula I, may be prepared in a known manner, typically by intimately mixing and/or grinding the compound with extenders, for example solvents, solid carriers and, optionally, surface active compounds (surfactants).
The agrochemical formulations and/or compositions will usually contain from 0.1 to 99% by weight, preferably from 0.1 to 95% by weight, of the compound of formula I, 99.9 to 1 % by weight, preferably 99.8 to 5% by weight, of a solid or liquid adjuvant, and from 0 to 25% by weight, preferably from 0.1 to 25% by weight, of a surfactant.
Advantageous rates of application are normally from 5g to 2kg of active ingredient (a.i.) per hectare (ha), preferably from 10g to 1 kg a.i./ha, most preferably from 20g to 600g a.i./ha. When used as seed drenching agent, convenient dosages are from 10mg to 1 g of active substance per kg of seeds.
Whereas it is preferred to formulate commercial products as concentrates, the end user will normally use dilute formulations.
The following non-limiting example illustrates the above-described invention in more detail.
Example 1 : This example illustrates the preparation of N-(2-{1 -[2-(3,5-bis-difluoromethyl- pyrazol-1-yl)-acetyl]-piperidin-4-yl}-thiazol-4-yl)-3-chloro-2-hydroxy-benzamide (Compound No. I.g.006) a) Preparation of 4-(4-hydroxycarbamoyl-thiazol-2-yl)-piperidine-1-carboxylic acid tert- butyl ester
To a solution of 4-(4-carboxy-thiazol-2-yl)-piperidine-1 -carboxylic acid tert-butyl ester (3.45 g, 0.01 mol) in acetonitrile (90 mL) is added slowly carbonyldiimidazol (1.93 g, 0.012 mol). After stirring 2h at RT, hydroxylamine hydrochloride (1.38 g, 0.02 mol) is added slowly to the reaction mixture. After stirring 1 h at RT, the reaction mixture is evaporated to half of the volume, and then the resulting oil is washed with aqueous saturated sodium bicarbonate solution, the aqueous phase is re-extracted with ethylacetate. The combined organic layers are washed with 1 M HCI solution and brine. Diethylether is added and then solid filtered, dry under high vacuum to give 4-(4-hydroxycarbamoyl-thiazol-2-yl)-piperidine-1-carboxylic acid tert-butyl ester which can be used in the next step without further purification. 1H-NMR (400 MHz, CDCI3): δ = 1 .45 (s, 9H), 1 .68-1.72 (m, 2H), 2.08-2.1 1 (m, 2H), 2.88-2.93 (m, 2H), 3.12-3.16 (m, 1 H), 4.15-4.22 (m, 2H), 8.00 (s, 1 H), 9.00 (br, 1 H). MS: m/z = 328 (M+1 ) b) Preparation of 4-(4-amino-thiazol-2-yl)-piperidine-1 -carboxylic acid tert-butyl ester To a solution of 4-(4-hydroxycarbamoyl-thiazol-2-yl)-piperidine-1 -carboxylic acid tert- butyl ester (0.2 g, 0.61 1 mmol) in dry DMF (3 mL) is added anhydrous dipotassium carbonate (0.085 g, 0.61 1 mmol) at RT. After stirring 2h at 85°C, the reaction mixture is cooled down to RT and water is added. The aqueous layer is washed with ethylacetate and the combined organic layers are washed with brine, dried over sodium sulafte, filtered, and evaporated under reduced pressure to give 4-(4-amino-thiazol-2-yl)-piperidine-1-carboxylic acid tert-butyl ester which can be used in the next step without further purification. 1H-NMR (400 MHz, CDCI3): δ = 1 .45 (s, 9H), 1 .55-1.65 (m, 2H), 1.90-2.01 (m, 2H), 2.72-2.81 (m, 2H), 2.90-2.97 (m, 1 H), 3.92-4.00 (m, 2H), 4.07-4.13 (br, 2H), 5.72 (s, 1 H). MS: m/z = 284 (M+1 ); 184 (M-100 +1 ). c) Preparation of 4-[4-(3-chloro-2-hydroxy-benzoylamino)-thiazol-2-yl]-piperidine-1 - carboxylic acid tert-butyl ester
To a solution 3-chlorosalicyclic acid (2.89 g, 16.7 mmol) in dry acetonitrile (20 mL) is added carbonyldiimidazol (2.71 g, 16.7 mmol). After stirring 3h at 60°C, a solution of DBU (3.18 g, 20.9 mmol) and 4-(4-amino-thiazol-2-yl)-piperidine-1-carboxylic acid tert-butyl ester (3.95 g, 13.9 mmol) in acetonitrile (10 mL) is added to the reaction mixture. After stirring overnight at RT, solvent is evaporated, the residue is dissolved in ethylacetate, washed with 0.5M HCI, the combined organic layers are washed with sodium bicarbonate, then with brine, dried over sodium sulafte, filtered, and evaporated under reduced pressure, diethyl ether is added to the residue oil and solid precipitated, filtered to give 4-[4-(3-chloro-2-hydroxy- benzoylamino)-thiazol-2-yl]-piperidine-1 -carboxylic acid tert-butyl ester. 1H-NMR (400 MHz, CDCI3): δ = 1 .45 (s, 9H), 1 .62-1.71 (m, 2H), 1.92-2.01 (m, 2H), 2.72-2.81 (m, 2H), 2.95-3.02 (m, 1 H), 4.08-4.17 (m, 2H), 6.80 (t, 1 H), 7.47-7.52 (m, 2H), 7.58 (s, 1 H). MS: m/z = 438 (M+1 ). d) Preparation of 3-chloro-2-hydroxy-N-(2-piperidin-4-yl-thiazol-4-yl)-benzamide
hydrochloride salt
To a solution of 4-[4-(3-chloro-2-hydroxy-benzoylamino)-thiazol-2-yl]-piperidine-1 -carboxylic acid tert-butyl ester (2.0 g, 4.57 mmol) in methanol (9mL) is added a solution of 4M HCI in dioxane (5.71 mL, 22.8 mmol)) at RT. After stirring overnight at RT, the solvent is evaporated under reduced pressure to give 3-chloro-2-hydroxy-N-(2-piperidin-4-yl-thiazol-4- yl)-benzamide hydrochloride salt. 1H-NMR (400 MHz, MeOD): δ = 1 .99 (q, 2H), 2.30 (d, 2H), 3.12 (t, 2H), 3.31 3.37 (m, 1 H), 3.43 (d, 2H), 6.89 (t, 1 H), 7.51 (d, 1 H), 7.67 (s, 1 H), 7.86 (d, 1 H). MS: m/z = 338 (M+1 ). e) Preparation of N-(2-{1 -[2-(3,5-bis-difluoromethyl-pyrazol-1 -yl)-acetyl]-piperidin-4-y l}-thiazol-4-yl)-3-chloro-2-hydroxy-benzamide (Compound No. I.g.006)
To solution of 2-[3,5-bis(difluoromethyl)pyrazol-1 -yl]acetic acid (0.024 g, 0.107 mmol) in dichloromethane (2 mL) is added one drop of DMF, followed by oxalyl chloride (0.015 g, 0.1 17 mmol) at RT. After gas evolution stopped, solvent and excess of oxalyl chloride are evaporated and the residue oil is dissolved in dichloromethane (2 mL) and is added to a solution of 3-chloro-2-hydroxy-N-(2-piperidin-4-yl-thiazol-4-yl)-benzamide hydrochloride salt and diisopropyllethylamine (0.069 g, 0.535 mmol) in dichloromethane (8 mL) at 0°C. After stirring 2h at RT, water is added to the reaction mixture, the combined organic layers are washed with 1 M HCI, then with brine, dried over sodium sulafte, filtered, and evaporated under reduced pressure. The residue is purified by column chromatography on silica gel (ethyl acetate/cyclohexane 7:3) to give N-(2-{1-[2-(3,5-bis-difluoromethyl-pyrazol-1-yl)- acetyl]-piperidin-4-yl}-thiazol-4-yl)-3-chloro-2-hydroxy-benzamide (Compound No. I.g.006). 1 H-NMR (400 MHz, CDCI3): δ = 1 .70-1.82 (m, 2H), 2.05-2.21 (m, 2H), 2.81-2.97 (m, 1 H), 3.1 1-3.20 (m, 1 H), 3.20-3.31 (m, 1 H), 3.80-3.90 (m, 1 H), 4.48-4.56 (m, 1 H), 5.09 (d, 2H), 6.6-6.82 (m, 2H), 6.82 (t, 1 H), 7.45 (d, 2H), 7.6 (s, 1 H), 9.02 (br, 1 H), 12.1 1 (br, 1 H). MS: m/z = 546 (M+1 ).
Table 1 below illustrates examples of individual compounds of formula I according to the invention.
Table 1 : individual compounds of formula I according to the invention
Figure imgf000028_0001
Figure imgf000029_0001
Figure imgf000030_0001
Figure imgf000031_0001
Figure imgf000032_0001
034
035
036
037
038
039
Figure imgf000034_0001
Figure imgf000035_0001
Figure imgf000036_0001
Figure imgf000037_0001
Figure imgf000038_0001
Figure imgf000039_0001
Figure imgf000040_0001
Figure imgf000041_0001
Figure imgf000042_0001
Figure imgf000043_0001
Figure imgf000044_0001
Figure imgf000045_0001
Figure imgf000046_0001
Figure imgf000047_0001
where
a) 139 compounds of formula (I. a):
Figure imgf000047_0002
wherein A, Q, R1 and R9 are as defined in Table 1. b) 139 compounds of formula (l.b):
Figure imgf000047_0003
wherein A, Q, R1 and R9 are as defined in Table 1. c) 139 compounds of formula (l.c):
Figure imgf000047_0004
wherein A, Q, R1 and R9 are as defined in Table 1. d) 139 compounds of formula (l.d):
Figure imgf000048_0001
wherein A, Q, R1 and R9 are as defined in Table 1 e 139 compounds of formula (l.e):
Figure imgf000048_0002
wherein A, Q, R1 and R9 are as defined in Table 1 f 139 compounds of formula (l.f):
Figure imgf000048_0003
wherein A, Q, R1 and R9 are as defined in Table 1. g) 139 compounds of formula (l.g):
Figure imgf000048_0004
wherein A, Q, R1 and R9 are as defined in Table 1. h) 139 compounds of formula (l.h):
Figure imgf000048_0005
wherein A, Q, R1 and R9 are as defined in Table 1. i) 139 compounds of formula (I. i):
Figure imgf000048_0006
wherein A, Q, R1 and R9 are as defined in Table 1. j) 139 compounds of formula (l.j):
Figure imgf000049_0001
wherein A, Q, R1 and R9 are as defined in Table 1. k) 139 compounds of formula (l.k):
Figure imgf000049_0002
wherein A, Q, R1 and R9 are as defined in Table 1. m) 139 compounds of formula (l.m):
Figure imgf000049_0003
wherein A, Q, R1 and R9 are as defined in Table 1. n) 139 compounds of formula (l.n):
Figure imgf000049_0004
wherein A, Q, R1 and R9 are as defined in Table 1. o) 139 compounds of formula (l.o):
Figure imgf000049_0005
wherein A, Q, R1 and R9 are as defined in Table 1. p) 139 compounds of formula (l.p):
Figure imgf000049_0006
wherein A, Q, R1 and R9 are as defined in Table 1. q) 139 compounds of formula (l.q):
Figure imgf000050_0001
wherein A, Q, R1 and R9 are as defined in Table 1. r) 139 compounds of formula (l.r):
Figure imgf000050_0002
wherein A, Q, R1 and R9 are as defined in Table 1. s) 139 compounds of formula (l.s):
Figure imgf000050_0003
wherein A, Q, R1 and R9 are as defined in Table 1. t 139 compounds of formula (l.t):
Figure imgf000050_0004
wherein A, Q, R1 and R9 are as defined in Table 1. u 139 compounds of formula (l.u):
Figure imgf000050_0005
wherein A, Q, R1 and R9 are as defined in Table 1. v 139 compounds of formula (I. v):
Figure imgf000050_0006
wherein A, Q, R1 and R9 are as defined in Table 1. w 139 compounds of formula (l.w):
Figure imgf000051_0001
wherein A, Q, R1 and R9 are as defined in Table 1. x 139 compounds of formula (I. x):
Figure imgf000051_0002
wherein A, Q, R1 and R9 are as defined in Table 1. 139 compounds of formula (l.y):
Figure imgf000051_0003
wherein A, Q, R1 and R9 are as defined in Table 1.
Throughout this description, temperatures are given in degrees Celsius and "m.p." means melting point. LC/MS means Liquid Chromatography Mass Spectroscopy and the description of the apparatus and the method is: (ACQUITY UPLC from Waters,
Phenomenex Gemini C18, 3 μηη particle size, 1 10 Angstrom, 30 x 3 mm column,
1 .7mL/min., 60 °C, H20 + 0.05% HCOOH (95%) / CH3CN/MeOH 4:1 + 0.04% HCOOH (5%) - 2 min. - CH3CN/MeOH 4:1 + 0.04% HCOOH (5%) - 0.8 min., ACQUITY SQD Mass Spectrometer from Waters, ionization method: electrospray (ESI), Polarity: positive ions, Capillary (kV) 3.00, Cone (V) 20.00, Extractor (V) 3.00, Source Temperature (°C) 150, Desolvation Temperature (°C) 400, Cone Gas Flow (L/Hr) 60, Desolvation Gas Flow (L/Hr) 700)).
Table 2: Melting point and LC/MS data for compounds of Table 1
Compound No. Melting point (°C) LC/MS
I.g.006 Rt=1 .93 min;MS: m/z=546 (M+1 ) Biological examples
Phytophthora infestans I tomato / leaf disc preventative (tomato late blight)
Tomato leaf disks are placed on water agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water. The leaf disks are inoculated with a spore suspension of the fungus 1 day after application. The inoculated leaf disks are incubated at 16°C and 75% rh under a light regime of 24 h darkness followed by 12 h light / 12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf disks (5 - 7 days after application).
Compound l.g.006 at 200 ppm gives at least 80% disease control in this test when compared to untreated control leaf discs under the same conditions, which show extensive disease development.
Phytophthora infestans I potato / preventative (potato late blight)
2-week old potato plants cv. Bintje are sprayed in a spray chamber with the formulated test compound diluted in water. The test plants are inoculated by spraying them with a sporangia suspension 2 days after application. The inoculated test plants are incubated at 18° C with 14 h light/day and 100 % rh in a growth chamber and the percentage leaf area covered by disease is assessed when an appropriate level of disease appears on untreated check plants (5 - 7 days after application).
Compound l.g.006 at 200 ppm gives at least 80% disease control in this test when compared to untreated control plants under the same conditions, which show extensive disease development.
Phytophthora infestans I potato / long lasting preventative (potato late blight)
2-week old potato plants cv. Bintje are sprayed in a spray chamber with the formulated test compound diluted in water. The test plants are inoculated by spraying them with a sporangia suspension 6 days after application. The inoculated test plants are incubated at 18° C with 14 h light/day and 100 % rh in a growth chamber and the percentage leaf area covered by disease is assessed when an appropriate level of disease appears on untreated check plants (9 - 1 1 days after application).
Compound l.g.006 at 200 ppm gives at least 80% disease control in this test when compared to untreated control plants under the same conditions, which show extensive disease development.
Phytophthora infestans I potato / curative (potato late blight)
2-week old potato plants cv. Bintje are inoculated by spraying them with a sporangia suspension one day before application. The inoculated plants are sprayed in a spray chamber with the formulated test compound diluted in water. The inoculated test plants are incubated at 18° C with 14 h light/day and 100 % rh in a growth chamber and the percentage leaf area covered by disease is assessed when an appropriate level of disease appears on untreated check plants (3 - 4 days after application).
Compound l.g.006 at 200 ppm gives at least 80% disease control in this test when compared to untreated control plants under the same conditions, which show extensive disease development. Plasmopara viticola I grape / leaf disc preventative (grape downy mildew)
Grape vine leaf disks are placed on water agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water. The leaf disks are inoculated with a spore suspension of the fungus 1 day after application. The inoculated leaf disks are incubated at 19°C and 80% rh under a light regime of 12 h light / 12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf disks (6 - 8 days after application).
Compound l.g.006 at 200 ppm gives at least 80% disease control in this test when compared to untreated control leaf discs under the same conditions, which show extensive disease development. Plasmopara viticola I grape / preventative (grape downy mildew)
5-week old grape seedlings cv. Gutedel are sprayed in a spray chamber with the formulated test compound diluted in water. The test plants plants are inoculated by spraying a sporangia suspension on their lower leaf surface one day after application. The inoculated test plants are incubated at 22° C and 100% rh in a greenhouse and the percentage leaf area covered by disease is assessed when an appropriate level of disease appears on untreated check plants (6 - 8 days after application).
Compound l.g.006 at 200 ppm gives at least 80% disease control in this test when compared to untreated control plants under the same conditions, which show extensive disease development.
Plasmopara viticola I grape / long lasting preventative (grape downy mildew)
5-week old grape seedlings cv. Gutedel are sprayed in a spray chamber with the formulated test compound diluted in water. The test plants are inoculated by spraying a sporangia suspension on their lower leaf surface 6 days after application. The inoculated test plants are incubated at 22° C and 100% rh in a greenhouse and the percentage leaf area covered by disease is assessed when an appropriate level of disease appears on untreated check plants (1 1 - 13 days after application).
Compound l.g.006 at 200 ppm gives at least 80% disease control in this test when compared to untreated control plants under the same conditions, which show extensive disease development. Plasmopara viticola I grape / curative (grape downy mildew)
5-week-old grape seedlings cv. Gutedel are inoculated by spraying a sporangia suspension on their lower leaf surface one day before application. The inoculated grape plants are sprayed in a spray chamber with the formulated test compound diluted in water. The inoculated test plants are incubated at 22° C and 100% rh in a greenhouse and the percentage leaf area covered by disease is assessed when an appropriate level of disease appears on untreated check plants (4 - 6 days after application).
Compound l.g.006 at 200 ppm gives at least 80% disease control in this test when compared to untreated control plants under the same conditions, which show extensive disease development. Pythium ultimum I liquid culture (seedling damping off)
Mycelia fragments and oospores of a newly grown liquid culture of the fungus are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal mycelia/spore mixture is added. The test plates are incubated at 24°C and the inhibition of growth is determined photometrically 2-3 days after application.
Compound l.g.006 at 200 ppm gives at least 80% disease control in this test when compared to untreated control culture under the same conditions, which show extensive disease development.
Pythium ultimum / cotton / soil drench (seedling damping off)
The test is carried out in plastic containers (650 ml volume) using a mixture of (50%
Vermiculit + sterile 50% Cugy soil) + 10% v/v water. 10 seeds (cotton, cv. Sure Grow 747) are sown in 2 rows of 5 seeds per container (3 replicates for evaluation of the activity, 3 replicates for evaluation of phytotox). Application is carried out directly after sowing by pouring 10 ml compound diluted in water per row over the seeds. Just afterwards the seeds are covered with a thin layer of the same soil and the inoculation is happening. Pythium ultimum is cultivated for 14 days on carrot slices in Roux bottles. For inoculation, the content of the Roux bottles is mixed and homogenously dispensed over the plastic containers without further filtering (70ml suspension per container). Incubation conditions: 20°C, 12h/12h day/night period in the greenhouse. The activity of a compound is assessed as percent disease control relative to untreated check plants when an appropriate level of disease damage appears in untreated check plants (13 - 16 days after application).
Compound l.g.006 at 200 ppm gives at least 80% disease control in this test when compared to untreated control plants under the same conditions, which show extensive disease development.

Claims

What is claimed is:
Figure imgf000056_0001
wherein
A is x-C(=0)-, x-C(=S)-, x-C(R10R11)-C(=O)-, x-C(R12R13)-C(=S)-, x-0-C(=0)-, x-0-C(=S)-, x-N(R14)-C(=0)-, x-N(R15)-C(=S)-, x-C(R16R17)-S02- or x-N=C(R26)-, in each case x indicates the bond that is connected to R1 ;
T is CR18 or N;
G is O or S;
Y1 and Y2 are independently CR19 or N;
Q is -C(=0)-z, -C(=S)-z, -C(=0)-0-z, -C(=S)-0-z, -C(=O)-N(R20)-z, -C(=S)-N(R21)-z or -S02- Z-, in each case z indicates the bond that is connected to R9;
n is 1 or 2;
p is 1 or 2, providing that when n is 2, p is 1 ;
R1 is
Figure imgf000056_0002
R2, R3, R4, R5, R6, R7, R10, R11, R12, R13, R16, R17, R18, R19 and R26 each independently are hydrogen, halogen, cyano, C1-C4alkyl or C1-C4haloalkyl;
R8, R14, R15, R20 and R21 each independently are hydrogen, CrC4alkyl or d-C4alkoxy; and R9 is henyl, benzyl or group (a):
Figure imgf000056_0003
(a)
wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C1-C4 alkyl, C1-C4 haloalkyi, C1-C4 alkoxy, C1-C4 haloalkoxy, halogen, cyano, hydroxyl, N(R )2, SH, C1-C4 alkylthio, nitro, phenylsulfonyl and phenylsulfinyl, wherein the phenylsulfonyl and phenylsulfinyl are optionally substituted by 1 to 3 substituents independently selected from C1-C4 alkyl, C1-C4 haloalkyi, C1-C4 alkoxy, Ci- C4 haloalkoxy, halogen and cyano;
each R27 independently is hydrogen, C1-C4 alkyl, phenylsulfonyl or phenylsulfinyl, wherein the phenylsulfonyl and phenylsulfinyl are optionally substituted by 1 to 3 substituents independently selected from C1-C4 alkyl, C1-C4 haloalkyi, C1-C4 alkoxy, C1-C4 haloalkoxy, halogen and cyano;
or a salt or a N-oxide thereof.
2. The compound according to claim 1 , wherein
A is x-C(=0)-, x-C(=S)-, x-C(R10R11)-C(=O)-, x-C(R12R13)-C(=S)-, x-0-C(=0)-, x-0-C(=S)-, x-N(R14)-C(=0)-, x-N(R15)-C(=S)- or x-C(R16R17)-S02-, in each case x indicates the bond that is connected to R1;
T is CR18 or N;
G is O or S;
Y1 and Y2 are independently CR19 or N;
Q is -C(=0)-z, -C(=S)-z, -C(=0)-0-z, -C(=S)-0-z, -C(=O)-N(R20)-z, -C(=S)-N(R21)-z or -S02- Z-, in each case z indicates the bond that is connected to R9;
n is 1 or 2;
p is 1 or 2, providing that when n is 2, p is 1 ;
R2, R3, R4, R5, R6, R7, R10, R11, R12, R13, R16, R17, R18 and R19 each independently are hydrogen, halogen, cyano, CrC4alkyl or d-C4haloalkyl;
R8, R14, R15, R20, and R21 each independently are hydrogen or C C4alkyl; and
R9 is henyl, benzyl or group (a):
Figure imgf000057_0001
(a)
wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C1-C4 alkyl, C1-C4 haloalkyi, halogen, cyano, hydroxy and amino.
3. The compound according to claim 1 , wherein
A is x-C(=0)-, x-C(=S)-, x-C(R10R11)-C(=O)-, x-C(R12R13)-C(=S)-, x-0-C(=0)-, x-0-C(=S)- or x-C(R16R17)-S02-, in each case x indicates the bond that is connected to R1;
T is CR18 or N; G is O or S;
Y1 is N;
Y2 is CR19 or N;
Q is -C(=0)-z, -C(=S)-z, -C(=0)-0-z, -C(=S)-0-z, -C(=O)-N(R20)-z, -C(=S)-N(R21)-z or -S02- Z-, in each case z indicates the bond that is connected to R9;
n is 1 or 2;
p is 1 ;
R2, R3, R4, R5, R6, R7, R10, R11, R12, R13, R16, R17, R18 and R19 each independently are hydrogen, halogen, d-C4alkyl or CrC4haloalkyl;
R8, R20 and R21 each independently are hydrogen or Ci-C4alkyl; and
R9 is henyl, benzyl or group (a):
(a)
wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C C4 alkyl, C C4 haloalkyi, halogen, cyano, hydroxy and amino.
4. The compound according to claim 1 , wherein
A is x-C(=0)-, -x-CR10R11-C(=O)-, x-0-C(=0)- or x-C(R16R17)-S02-, in each case x indicates the bond that is connected to R1 ;
T is CR18 or N;
G is S;
Y1 is N;
Y2 is CR19 or N;
Q is -C(=0)-z, -C(=0)-0-z, -C(=O)-N(R20)-z or -S02-z-, in each case z being the bond to R9; n is 1 or 2;
p is 1 ;
R2, R3, R4, R5, R6, R7, R10, R11 , R16, R17, R18, and R19 each independently are hydrogen, fluoro or methyl;
R8 and R20 each independently are hydrogen or methyl; and
R9 is phenyl, benzyl or group (a):
Figure imgf000058_0002
(a)
wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C1-C4 alkyl, C1-C4 haloalkyi, hydroxy and halogen. 5. The compound according to claim 1 , wherein
A is x-C(=0)-, x-CH2-C(=0)-, x-0-C(=0)- or x-CH2-S02-, in each case x indicates the bond that is connected to R1;
T is CH or N;
G is S;
Y1 is N;
Y2 is CH or N;
Q is -C(=0)-z, -C(=0)-0-z, -C(=0)-NH-z or -S02-z-, in each case z indicates the bond that is connected to R9;
n is 1 or 2;
p is 1 ;
R2, R3, R4, R5, R6 and R7 are each hydrogen;
R8 is hydrogen; and
R9 is henyl, benzyl or group (a):
Figure imgf000059_0001
(a)
wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C1-C4 alkyl, C1-C4 haloalkyi, hydroxy and halogen.
6. The compound according to claim 1 , wherein
A is x-CH2-C(=0)- wherein x indicates the bond that is connected to R1;
T is CH;
G is S;
Y1 is N;
Y2 is CH;
Q is -C(=0)-z, -C(=0)-0-z or C(=O)-N(R20)-z, in each case z indicates the bond that is connected to R9;
n is 2;
p is 1 ;
R2> R3> R4> Rs, R6> and R7 are each hydrogen;
R8, is hydrogen; R9 is henyl, benzyl or group (a)
Figure imgf000060_0001
(a)
wherein the phenyl, benzyl and group (a) are optionally substituted with 1 to 3 substituents
5 independently selected from halogen, hydroxy, methyl and halomethyl.
7. The compound according to any one of claims 1 to 6, wherein G is S, Y1 is N and Y2 is CH.
10 8. The compound according to any one of claims 1 to 7, wherein p is 1 and n is 2.
9. The compound according to any one of the claims 1 to 8, wherein R2, R3, R4, R5, R6 and R7 are H.
15 10. The compound according to any one of claims 1 to 9, wherein Q is -C(=0)-z, wherein z indicates the bond that is connected to R9.
1 1. The compound according to any one of claims 1 to 10, wherein R9 is phenyl substituted by hydroxy and optionally substituted by one or two further substituents.
20
12. The compound according to claim 1 1 , wherein the hydroxy is at the ortho position.
Figure imgf000060_0002
25 wherein R1 , R2, R3, R4, R5, R6, R7, R8, A, T, G, Y1 , Y2, n and p are as defined for formula I in any one of claims 1 to 12; or a compound of formula VIII:
Figure imgf000061_0001
wherein R1 , R2, R3, R4, R6, R7, R8, A, T, G, Y1, Y2 , p and n are as defined for formula I in any one of claims 1 to 12. 14. A fungicidal composition comprising at least one compound as defined in any one of claims 1 to 12 and an agriculturally acceptable carrier, optionally comprising an adjuvant, and optionally comprising at least one additional fungicidally active compound.
15. A method of controlling or preventing an infestation of plants, propagation material thereof, harvested crops or non-living materials by phytopathogenic or spoilage
microorganisms or organisms potentially harmful to man, which comprises the application of a compound as defined in any one of claims 1 to 12, to the plant, to parts of the plants or to the locus thereof, to propagation material thereof or to any part of the non-living materials; wherein the phytopathogenic microorganisms are preferably fungal organisms.
PCT/EP2012/062425 2011-06-30 2012-06-27 Microbiocidal heterocycles WO2013000941A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161503247P 2011-06-30 2011-06-30
US61/503,247 2011-06-30

Publications (1)

Publication Number Publication Date
WO2013000941A1 true WO2013000941A1 (en) 2013-01-03

Family

ID=46420168

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/062425 WO2013000941A1 (en) 2011-06-30 2012-06-27 Microbiocidal heterocycles

Country Status (4)

Country Link
AR (1) AR086784A1 (en)
TW (1) TW201313704A (en)
UY (1) UY34169A (en)
WO (1) WO2013000941A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014060176A1 (en) * 2012-10-16 2014-04-24 Syngenta Participations Ag Microbiocidal pyrazole derivatives
WO2014118142A1 (en) * 2013-02-01 2014-08-07 Syngenta Participations Ag Microbiocidal pyrazole derivatives
WO2014124878A1 (en) 2013-02-15 2014-08-21 Syngenta Participations Ag Process for the preparation of bis-dihaloalkyl pyrazoles
WO2015117912A1 (en) * 2014-02-07 2015-08-13 Syngenta Participations Ag Pesticidally active amide derivatives with sulphur containing substituents
KR20170036104A (en) 2014-08-13 2017-03-31 가부시키가이샤 에스디에스 바이오텍크 Condensed 11-member ring compound and agriculture and horticultural fungicide comprising same
US11274076B2 (en) 2016-02-08 2022-03-15 Gowan Company, L.L.C. Process for preparing 1, 2-benzenedimethanol compound
WO2022117064A1 (en) * 2020-12-04 2022-06-09 Eubulus Biotherapeutics Inc. Heteroaryl-acetylenes, pharmaceutical compositions thereof, and their therapeutic applications
WO2023012044A1 (en) * 2021-08-02 2023-02-09 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
US11903387B2 (en) 2016-02-08 2024-02-20 Gowan Company, L.L.C. Fungicidal composition

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0353191A2 (en) 1988-07-29 1990-01-31 Ciba-Geigy Ag DNA sequences encoding polypeptides having beta-1,3-glucanase activity
EP0392225A2 (en) 1989-03-24 1990-10-17 Ciba-Geigy Ag Disease-resistant transgenic plants
WO1995033818A2 (en) 1994-06-08 1995-12-14 Ciba-Geigy Ag Genes for the synthesis of antipathogenic substances
WO1997033890A1 (en) 1996-03-11 1997-09-18 Novartis Ag Pyrimidin-4-one derivatives as pesticide
WO2009132785A1 (en) * 2008-04-30 2009-11-05 Bayer Cropscience Aktiengesellschaft Thiazol-4-carboxylic acid esters and thioesters as plant protection agents
WO2011018401A1 (en) 2009-08-12 2011-02-17 Syngenta Participations Ag Microbiocidal heterocycles

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0353191A2 (en) 1988-07-29 1990-01-31 Ciba-Geigy Ag DNA sequences encoding polypeptides having beta-1,3-glucanase activity
EP0392225A2 (en) 1989-03-24 1990-10-17 Ciba-Geigy Ag Disease-resistant transgenic plants
WO1995033818A2 (en) 1994-06-08 1995-12-14 Ciba-Geigy Ag Genes for the synthesis of antipathogenic substances
WO1997033890A1 (en) 1996-03-11 1997-09-18 Novartis Ag Pyrimidin-4-one derivatives as pesticide
WO2009132785A1 (en) * 2008-04-30 2009-11-05 Bayer Cropscience Aktiengesellschaft Thiazol-4-carboxylic acid esters and thioesters as plant protection agents
WO2011018401A1 (en) 2009-08-12 2011-02-17 Syngenta Participations Ag Microbiocidal heterocycles

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
A. ALBINI; S. PIETRA: "Heterocyclic N-oxides", 1991, CRC PRESS

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014060176A1 (en) * 2012-10-16 2014-04-24 Syngenta Participations Ag Microbiocidal pyrazole derivatives
WO2014118142A1 (en) * 2013-02-01 2014-08-07 Syngenta Participations Ag Microbiocidal pyrazole derivatives
WO2014124878A1 (en) 2013-02-15 2014-08-21 Syngenta Participations Ag Process for the preparation of bis-dihaloalkyl pyrazoles
WO2015117912A1 (en) * 2014-02-07 2015-08-13 Syngenta Participations Ag Pesticidally active amide derivatives with sulphur containing substituents
KR20170036104A (en) 2014-08-13 2017-03-31 가부시키가이샤 에스디에스 바이오텍크 Condensed 11-member ring compound and agriculture and horticultural fungicide comprising same
US9980487B2 (en) 2014-08-13 2018-05-29 Sds Biotech K.K. Fused 11-membered compounds and agricultural/horticultural fungicides containing them
US10104891B2 (en) 2014-08-13 2018-10-23 Sds Biotech K.K. Fused 11-membered compounds and agricultural/horticultural fungicides containing them
US11274076B2 (en) 2016-02-08 2022-03-15 Gowan Company, L.L.C. Process for preparing 1, 2-benzenedimethanol compound
US11903387B2 (en) 2016-02-08 2024-02-20 Gowan Company, L.L.C. Fungicidal composition
WO2022117064A1 (en) * 2020-12-04 2022-06-09 Eubulus Biotherapeutics Inc. Heteroaryl-acetylenes, pharmaceutical compositions thereof, and their therapeutic applications
WO2023012044A1 (en) * 2021-08-02 2023-02-09 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives

Also Published As

Publication number Publication date
TW201313704A (en) 2013-04-01
UY34169A (en) 2013-01-31
AR086784A1 (en) 2014-01-22

Similar Documents

Publication Publication Date Title
US8557821B2 (en) Microbiocidal heterocycles
US8367844B2 (en) Microbiocidal heterocycles
EP2643312B1 (en) Microbicidal heterocycles
EP2516424B1 (en) Pyrazole derivatives
WO2012107475A1 (en) Microbiocidal pyrazole derivatives
EP2820015A1 (en) Microbiocidal pyrazole derivatives
EP2768829A1 (en) Microbiocidal pyrazole derivatives
WO2014075874A1 (en) Microbiocidal pyrazole derivatives
WO2013000941A1 (en) Microbiocidal heterocycles
WO2014075873A1 (en) Microbiocidal pyrazole derivatives
US20160007606A1 (en) Microbiocidal pyrazole derivatives
WO2012107477A1 (en) Microbiocidal pyrazole derivatives
WO2013056911A1 (en) Microbiocidal pyrazole derivatives
WO2014118143A1 (en) Microbiocidal pyrazole derivatives
WO2014118142A1 (en) Microbiocidal pyrazole derivatives
WO2014154530A1 (en) Microbiocidal pyrazole derivatives
EP2820011A1 (en) Microbiocidal pyrazole derivatives
US9301530B2 (en) Microbiocidal heterocycles
WO2014060176A1 (en) Microbiocidal pyrazole derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12730934

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12730934

Country of ref document: EP

Kind code of ref document: A1